info icon

Primary_lymphoid and hematopoietic malignant neoplasms

CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC

lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

10331

6. Filter based on genotype QC (FinnGen only)

10331

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Similar endpoints

List of similar endpoints to Primary_lymphoid and hematopoietic malignant neoplasms based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 10331 4486 5845
Unadjusted period prevalence (%) 2.12 1.53 2.58
Median age at first event (years) 64.96 62.95 66.50

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
9449
Matched controls
94489
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
323.0
454
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
323.0
343
*
329
Kela drug reimbursment
Lenalidomide
1861.7
323.0
378
*
XW000
NOMESCO Finland
Bone marrow biopsy
46.3
323.0
3331
1099
H02AB06
ATC
prednisolone; systemic
2.3
323.0
5162
32098
J05AB11
ATC
valaciclovir; oral
3.8
323.0
1959
6109
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
1226.3
323.0
788
7
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
323.0
3438
11321
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
53.1
323.0
612
123
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
31.1
323.0
656
226
JN4AD
NOMESCO Finland
Body CT examination
5.0
323.0
1655
3827
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
13.6
323.0
624
488
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
30.0
323.0
1353
524
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
5910.7
323.0
567
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
1616.6
323.0
733
5
A04AA01
ATC
ondansetron; systemic, rectal
9.9
323.0
2064
2592
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
2461.1
323.0
1371
7
WW300
NOMESCO Finland
Transfer of autologic stem cells
2537.1
323.0
502
*
H02AB02
ATC
dexamethasone; systemic
5.4
323.0
2145
4889
ZX112
NOMESCO Finland
Subcutaneous
11.5
323.0
725
680
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
323.0
404
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
323.0
426
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
19.0
323.0
1266
763
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
323.0
481
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
39.8
323.0
1076
304
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
32.9
323.0
782
258
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.1
323.0
593
446
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
323.0
365
*
1XC02
NOMESCO Finland
NA
53.2
323.0
519
103
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
3599.8
323.0
357
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
263.3
323.0
5819
572
C90.0
ICD-10 Finland
Multiple myeloma
2550.6
323.0
1385
6
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.1
323.0
941
1019
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
8630.2
323.0
802
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
323.0
310
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
29.8
323.0
493
174
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
3793.6
323.0
375
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
323.0
400
*
L03AA02
ATC
filgrastim; parenteral
50.6
323.0
2104
532
WW500
NOMESCO Finland
Blood transfusion
13.1
323.0
1599
1441
L04AX04
ATC
lenalidomide; oral
+∞
323.0
559
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
51.4
323.0
916
197
PJA10
NOMESCO Finland
Exploration of lymph nodes
36.7
323.0
724
213
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.6
323.0
1160
1518
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
323.0
382
*
R50.9
ICD-10 Finland
Fever, unspecified
4.3
323.0
2464
7223
153
Kela drug reimbursment
Lenalidomid
3129.8
323.0
608
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
14.3
323.0
1828
1555
M04AA01
ATC
allopurinol; systemic
6.8
323.0
3617
7850
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.9
323.0
1926
2380
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
323.0
339
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
162.8
323.0
494
32
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
323.0
2210
7144
ZX120
NOMESCO Finland
Intravenous
5.0
323.0
1959
4689
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
17.9
323.0
584
347
JN6AD
NOMESCO Finland
CT of torso and neck
31.1
323.0
713
247
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
11073.9
323.0
1820
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
323.0
5189
31291
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
323.0
2175
5987
L03AA13
ATC
pegfilgrastim; parenteral
13.6
323.0
1341
1132
JN4BD
NOMESCO Finland
Extensive body CT
6.0
323.0
2727
5957
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
323.0
746
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
319.5
305
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.7
314.5
1181
2799
A04AA02
ATC
granisetron; systemic, transdermal
4.8
304.9
1119
2585
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
304.8
291
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
304.8
291
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
296.3
3676
20079
N02AA05
ATC
oxycodone; systemic
2.9
293.6
2158
8771
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
289.0
276
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
23.6
288.5
421
186
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
1411.7
280.3
272
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
62.9
279.6
328
54
WW409
NOMESCO Finland
Other aferesis
557.9
274.9
272
5
J05AB01
ATC
aciclovir; systemic
2.6
272.6
2430
11030
L01AA02
ATC
chlorambucil; oral
176.9
262.7
275
16
212
Kela drug reimbursment
Gout
8.1
261.4
618
806
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
61.3
257.3
303
51
ZX108
NOMESCO Finland
Inhalation
24.2
248.0
359
154
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
20.6
244.9
373
188
J01MA12
ATC
levofloxacin; systemic
2.5
242.3
2412
11514
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
241.9
955
2350
D70.89
ICD-10 Finland
Neutropenic splenomegaly
14.8
233.5
403
284
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
229.0
219
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
12.6
227.5
421
348
A02BC02
ATC
pantoprazole; systemic
2.0
220.2
6348
47475
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
12.8
218.7
402
327
YNB10
NOMESCO Finland
Collection of stem cells for transplant
1088.1
218.5
213
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
2014.5
214.2
207
*
L03AA14
ATC
lipegfilgrastim; parenteral
9.6
212.0
452
493
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
211.2
202
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
18.0
211.1
337
194
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.6
210.0
652
1231
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
40.8
206.6
262
66
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.2
205.3
844
2146
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
8.4
202.4
467
582
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.7
200.2
401
389
L01AA03
ATC
melphalan; systemic
668.8
199.9
197
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
199.6
191
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
198.2
1479
5909
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.8
197.8
416
442
C84.0
ICD-10 Finland
Mycosis fungoides
1838.3
196.4
190
*
127
Kela drug reimbursment
Transplant complication
9.6
192.6
409
442
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
192.3
2904
16539
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.5
191.7
410
449
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
1786.6
191.1
185
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.2
190.0
631
1285
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.6
188.1
582
1091
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
188.1
180
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.7
185.0
679
1539
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
19.5
183.3
284
150
WW402
NOMESCO Finland
Leucoferesis
613.2
183.3
181
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
8.6
182.2
412
496
WW200
NOMESCO Finland
Immunization
5.8
179.3
539
975
AA1AA
NOMESCO Finland
Head X-ray examination
14.8
176.7
304
212
H02AB07
ATC
prednisone; oral
2.4
176.6
1705
7831
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
174.7
679
1628
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
174.5
167
*
L01BB05
ATC
fludarabine; systemic
+∞
173.4
166
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
155.4
173.1
183
12
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.7
166.7
787
2248
XX9CD
NOMESCO Finland
Very extensive complementary CT
554.2
165.6
164
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.7
165.1
595
1320
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
13.9
161.0
284
210
189
Kela drug reimbursment
Imatinib
52.1
160.6
194
38
H02AB09
ATC
hydrocortisone; systemic
6.3
159.4
448
742
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
156.7
1877
9518
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
155.3
2292
12715
B73
ICPC
Leukaemia
316.1
155.3
157
5
TGC00
NOMESCO Finland
Bronchial lavation
5.2
147.7
487
979
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
146.9
1202
5000
390
Kela drug reimbursment
Ibrutinib
+∞
146.2
140
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
146.2
140
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
144.8
3272
21154
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
143.0
137
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
143.0
137
*
TAB00
NOMESCO Finland
Lumbar puncture
4.0
142.5
611
1599
A05AA02
ATC
ursodeoxycholic acid; oral
8.9
140.4
311
361
B01AB05
ATC
enoxaparin; parenteral
1.8
140.1
3086
19724
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
181.4
136.9
143
8
L01XE01
ATC
[U] imatinib; oral
50.8
136.1
165
33
L01BB02
ATC
mercaptopurine; oral
12.8
135.1
247
198
1512
Kela drug reimbursment
Ibrutinib
+∞
133.6
128
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
133.6
128
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
133.5
2355
13866
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
132.6
127
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
657.2
131.9
130
*
J01MA14
ATC
moxifloxacin; systemic
2.6
131.4
1055
4326
B72
ICPC
Hodgkin Lymphoma
331.6
130.8
132
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
36.4
129.6
168
47
393
Kela drug reimbursment
Pomalidomide
+∞
129.4
124
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
1265.4
128.4
125
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
10.5
128.4
258
251
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
127.3
122
*
B03XA02
ATC
darbepoetin alfa; parenteral
5.8
126.0
375
667
XX3DW
NOMESCO Finland
Time consuming IT work
2.4
122.4
1179
5320
Z51.5
ICD-10 Finland
Palliative care
2.8
121.6
839
3133
L01AA01
ATC
cyclophosphamide; systemic
20.4
121.0
184
92
1XX32
NOMESCO Finland
NA
600.7
120.4
119
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
119.0
114
*
WF004
NOMESCO Finland
Palliative radiotherapy
5.3
117.4
376
729
1507
Kela drug reimbursment
Pomalidomide
+∞
116.9
112
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
114.8
110
*
WF002
NOMESCO Finland
Radical radiotherapy
3.0
113.2
714
2511
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.8
111.3
507
1394
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
62.7
111.2
130
21
L04AX06
ATC
pomalidomide; oral
+∞
110.6
106
*
J02AC03
ATC
voriconazole; systemic
41.4
110.4
139
34
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
544.2
109.0
108
*
1AA09
NOMESCO Finland
NA
+∞
108.5
104
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
58.9
108.4
128
22
C91.7
ICD-10 Finland
Other lymphoid leukaemia
1060.4
107.6
105
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
107.5
103
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.9
106.6
702
2538
L01XE27
ATC
[U] ibrutinib; oral
+∞
104.3
100
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.5
103.5
384
872
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.2
100.8
408
1008
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
8.3
100.5
231
285
A07AA02
ATC
nystatin; oral
2.7
99.8
761
3004
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
24.2
99.5
143
60
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
99.3
707
2678
ZXE00
NOMESCO Finland
One hour or less
1.6
99.3
3587
25855
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
330.5
98.2
99
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
23.6
98.1
142
61
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
98.1
94
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
958.2
97.2
95
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
97.0
93
*
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
94.9
91
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
94.6
4276
32494
Z52.89
ICD-10 Finland
Donor of other organ or tissue
316.8
94.0
95
*
B74
ICPC
Malignant neoplasm blood other
46.5
93.6
115
25
1CX01
NOMESCO Finland
NA
38.9
93.4
119
31
Z85.6
ICD-10 Finland
Personal history of leukaemia
917.4
93.0
91
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.7
90.7
427
1204
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
89.5
1117
5635
C03CA01
ATC
furosemide; systemic
1.6
89.0
3081
21781
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
88.7
85
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
185.7
88.4
92
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
88.2
2730
18727
WZC30
NOMESCO Finland
Teaching
2.0
88.1
1325
7204
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
87.6
84
*
B03XA01
ATC
erythropoietin; parenteral
7.8
87.5
209
274
JN4CD
NOMESCO Finland
Very extensive body CT
3.0
86.1
526
1803
B01AB10
ATC
tinzaparin; parenteral
2.4
85.7
768
3306
L01EL01
ATC
ibrutinib; oral
+∞
85.5
82
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
85.5
82
*
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
85.5
82
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
85.3
901
4211
L04AD01
ATC
ciclosporin; systemic
4.9
84.7
292
614
L04AX02
ATC
thalidomide; oral
129.8
84.1
90
7
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
+∞
83.4
80
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
83.1
762
3317
ZX131
NOMESCO Finland
Intrathecal
214.3
82.4
85
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
82.2
896
4246
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
67.7
81.5
94
14
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
81.4
3423
25252
398
Kela drug reimbursment
Ixazomib
+∞
80.3
77
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
80.1
1794
11153
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
+∞
79.3
76
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.4
78.7
248
472
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
23.8
78.4
113
48
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
78.3
2442
16675
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
78.1
820
3814
M05BA02
ATC
clodronic acid; systemic
11.9
77.9
146
124
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
7.9
76.2
179
229
399
Kela drug reimbursment
Venetoclax
+∞
76.1
73
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
76.1
73
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
9.4
75.9
161
174
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
75.5
1091
5812
1505
Kela drug reimbursment
Ixazomib
+∞
75.1
72
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
75.1
72
*
B02.9
ICD-10 Finland
Zoster without complication
2.5
74.3
626
2604
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
22.7
74.0
108
48
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
73.0
70
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
73.0
70
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
72.5
643
2745
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
72.3
429
1439
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
71.9
69
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.4
71.8
367
1104
316
Kela drug reimbursment
Imatinib
60.5
71.7
84
14
D69.5
ICD-10 Finland
Secondary thrombocytopenia
19.3
70.9
109
57
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
70.5
1033
5526
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
70.4
985
5176
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
13.2
69.5
124
95
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
683.2
69.1
68
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
68.8
66
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
673.0
68.1
67
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
67.8
65
*
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
67.0
509
1996
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
66.7
64
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
66.7
64
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
66.7
64
*
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
66.7
64
*
WX110
NOMESCO Finland
Local anesthesy
1.5
66.0
5635
47566
ZXD05
NOMESCO Finland
Urgent procedure
1.5
65.8
2711
19652
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
+∞
65.7
63
*
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
65.7
63
*
152
Kela drug reimbursment
Nilotinib
+∞
63.6
61
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
11.1
62.6
121
110
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
62.6
60
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
97.9
61.9
68
7
L01XX05
ATC
hydroxycarbamide; oral
4.9
61.5
208
429
150
Kela drug reimbursment
Dasatinib
+∞
61.5
59
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
61.5
59
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
61.5
59
*
5BA08
NOMESCO Finland
NA
9.0
61.3
133
150
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
13.7
61.0
107
79
L01XX52
ATC
venetoclax; oral
+∞
60.5
58
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
8.1
60.4
139
173
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.7
60.3
280
781
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
59.4
57
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
59.4
57
*
TK800
NOMESCO Finland
Hemodialysis
3.5
58.6
287
835
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
25.8
58.5
82
32
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
58.4
56
*
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
+∞
58.4
56
*
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
58.4
56
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.6
58.0
176
321
TPX15
NOMESCO Finland
Removal of vascular injection port
9.7
57.9
120
125
J02AC01
ATC
fluconazole; systemic
1.5
57.7
2789
20808
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
57.6
368
1297
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
57.4
322
1039
L01XE06
ATC
[U] dasatinib; systemic
+∞
57.3
55
*
L01CB01
ATC
etoposide; systemic
9.5
56.7
119
127
Z3231
NOMESCO Finland
Registered nurse
1.5
56.2
2436
17730
Z2221
NOMESCO Finland
Medical doctor
1.5
56.1
2335
16840
L04AA06
ATC
mycophenolic acid; systemic
4.1
55.5
225
557
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
8.1
55.2
127
158
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.2
53
*
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
55.2
53
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
20.4
55.2
83
41
N02BE01
ATC
paracetamol; systemic, rectal
1.5
54.4
7539
68485
121
Kela drug reimbursment
Severe hypofunction of sexual glands
4.1
54.3
218
535
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
53.8
870
4801
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
12.7
53.7
97
77
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
18.0
53.5
84
47
Z2446
NOMESCO Finland
Social worker
2.2
53.4
613
2952
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
53.2
51
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
53.2
51
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
8.2
53.0
121
149
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
12.8
52.7
95
75
A02BC01
ATC
omeprazole; systemic
1.5
52.5
2427
17858
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
52.4
2909
22218
6BA02
NOMESCO Finland
NA
14.2
52.3
90
64
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
52.1
50
*
J01DB01
ATC
cefalexin; oral
1.4
52.0
6990
62685
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
51.1
49
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.2
50.7
276
871
9691/3-C42.1
ICD-O-3
Follicular lymphoma, grade 2 of bone marrow
+∞
50.0
48
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
50.0
48
*
1518
Kela drug reimbursment
NA
+∞
50.0
48
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
50.0
48
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.4
50.0
154
287
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
6.5
50.0
133
206
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
7.7
49.9
119
157
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
7.7
49.9
118
154
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.4
49.7
153
285
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
14.3
49.6
85
60
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
5.2
49.5
158
307
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.1
49.3
202
506
N02AX02
ATC
tramadol; systemic, rectal
1.4
49.1
3617
29028
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
49.0
47
*
J02AC04
ATC
posaconazole; systemic
79.1
48.9
55
7
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
18.2
48.7
76
42
L04AA01
ATC
[U] ciclosporin; systemic
4.1
48.6
199
498
A41.8
ICD-10 Finland
Other specified sepsis
3.7
48.5
219
597
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
48.5
855
4858
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
48.4
858
4880
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
246.2
48.0
49
*
372
Kela drug reimbursment
Idelalisib
+∞
47.9
46
*
N05CF01
ATC
zopiclone; oral
1.4
47.8
2788
21409
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
47.6
459
2038
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
5.8
47.3
137
237
20199
ICD-8 Finland
Hodgkin's disease
55.3
46.5
55
10
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
460.0
46.3
46
*
R06AE07
ATC
cetirizine; oral
1.4
46.1
3243
25726
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.7
46.1
334
1273
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
74.8
46.0
52
7
ZX121
NOMESCO Finland
Central venous catheter
9.8
45.7
94
97
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
45.6
3093
24361
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
449.9
45.3
45
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
45.2
280
968
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
44.8
43
*
L01XX50
ATC
[U] ixazomib; oral
+∞
44.8
43
*
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
44.8
43
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
19.6
44.7
68
35
N03AX16
ATC
pregabalin; oral
1.5
44.7
1898
13639
A06AD11
ATC
lactulose; oral
1.6
44.4
1373
9167
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.3
44.3
170
401
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
44.0
1535
10548
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
12.2
43.6
80
66
E83.50
ICD-10 Finland
Hypercalcemia
4.3
43.6
168
398
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.0
42.9
121
203
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.2
42.8
239
770
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
42.7
41
*
L01XE08
ATC
[U] nilotinib; oral
+∞
42.7
41
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
42.7
41
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
42.4
795
4603
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
19.5
42.1
64
33
R4110
NOMESCO Finland
Physiotherapy
1.4
42.0
2220
16641
L01XX28
ATC
[D] imatinib; oral
92.5
41.8
46
5
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
7.9
41.7
97
124
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
41.7
40
*
L01XX47
ATC
[U] idelalisib; oral
+∞
40.6
39
*
C91
ICD-10 Finland
Lymphoid leukaemia
+∞
40.6
39
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
7.3
40.6
99
136
J01CA04
ATC
amoxicillin; systemic
1.4
40.4
6622
59702
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
22.0
40.4
59
27
9101
FHL
Bone biopsy
15.8
40.3
66
42
4701
FHL
Neck lymph node removal
14.7
39.7
67
46
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.9
39.7
248
863
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
39.6
38
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
39.5
1743
12582
FM1FN
NOMESCO Finland
Heart function isotope examination
8.7
39.2
86
100
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.8
39.1
172
460
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
389.1
39.1
39
*
GEA00
NOMESCO Finland
Mediastinoscopy
8.5
38.8
86
102
C81
ICD-10 Finland
Hodgkin lymphoma
+∞
38.6
37
*
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
38.6
37
*
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
38.6
37
*
ZX114
NOMESCO Finland
Intramuscular
3.8
38.5
170
456
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
38.4
631
3488
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
63.1
38.1
44
7
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
37.9
405
1885
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.7
37.9
809
4872
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
37.5
36
*
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
37.5
36
*
2041A
ICD-9 Finland
Lymphoid leukaemia, Chronic
+∞
37.5
36
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
37.5
36
*
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
37.5
36
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
37.2
1425
9965
JAH21
NOMESCO Finland
Staging laparoscopy
368.8
37.0
37
*
3AA13
NOMESCO Finland
NA
14.8
37.0
62
42
Z31.6
ICD-10 Finland
General counselling and advice on procreation
6.9
36.9
94
138
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
25.6
36.6
51
20
WX402
NOMESCO Finland
General anaesthesia
1.5
36.5
1233
8376
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
36.5
35
*
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
36.5
35
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
36.5
35
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
36.2
664
3809
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
10.8
36.2
70
65
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
35.9
2791
22270
A79
ICPC
Malignancy NOS
3.6
35.9
165
459
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
35.7
553
2995
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
8.5
35.6
79
94
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
6.6
35.5
93
142
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
35.4
34
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
35.4
34
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
35.4
34
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
35.4
34
*
EMA10
NOMESCO Finland
Biopsy of tonsil
9.8
35.3
72
74
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
35.0
3168
25869
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
24.6
34.8
49
20
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.0
34.6
472
2436
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
36.8
34.6
44
12
J01MA02
ATC
ciprofloxacin; systemic
1.3
34.6
3286
27018
A04AD12
ATC
aprepitant; systemic
3.1
34.5
194
629
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
34.4
33
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
34.4
33
*
9659/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS
+∞
34.4
33
*
9659/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions
+∞
34.4
33
*
324
Kela drug reimbursment
Dasatinib
+∞
34.4
33
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
12.0
34.2
63
53
306
Kela drug reimbursment
Erythropoietin and darbepoetin
8.2
34.0
77
95
120
Kela drug reimbursment
Hypogammaglobulinaemia
17.8
33.9
53
30
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.1
33.9
68
68
2AX04
NOMESCO Finland
NA
27.2
33.6
46
17
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.4
33.5
295
1253
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
18.0
33.5
52
29
GA5AA
NOMESCO Finland
Rib X-ray examination
7.9
33.4
77
98
328
Kela drug reimbursment
Nilotinib
+∞
33.3
32
*
C82
ICD-10 Finland
Follicular lymphoma
+∞
33.3
32
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
33.3
32
*
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
33.3
32
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.0
33.2
195
653
UJF32
NOMESCO Finland
Coloscopy
1.4
32.9
2158
16692
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
170.6
32.7
34
*
L03AA10
ATC
lenograstim; parenteral
117.1
32.7
35
*
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.5
32.5
117
261
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.1
32.4
388
1902
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
+∞
32.3
31
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
32.3
31
*
1XX02
NOMESCO Finland
NA
+∞
32.3
31
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
32.3
31
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.3
31
*
L01EA03
ATC
nilotinib; oral
+∞
32.3
31
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
32.3
1550
11328
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
40.2
32.1
40
10
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.5
31.8
263
1081
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
31.8
1219
8503
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
31.6
341
1596
B59
ICD-10 Finland
Pneumocystosis
36.5
31.4
40
11
A07AA09
ATC
vancomycin; oral
3.6
31.4
147
416
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
31.3
30
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
31.3
30
*
L01XG03
ATC
ixazomib; oral
+∞
31.3
30
*
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
31.3
30
*
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
31.3
30
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.0
31.1
101
202
WX002
NOMESCO Finland
Sedation and analgesia
1.4
31.1
1619
12002
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
31.1
1385
9960
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
10.4
31.0
61
59
JAH20
NOMESCO Finland
Staging laparotomy
85.4
30.7
34
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
8.2
30.6
69
85
L03AB05
ATC
interferon alfa-2b; parenteral
6.8
30.5
78
116
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
30.4
1994
15390
1BC01
NOMESCO Finland
NA
+∞
30.2
29
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.8
30.2
194
690
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
30.1
350
1693
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.5
29.9
143
412
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.4
29.8
149
445
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
16.1
29.7
48
30
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
29.7
529
3003
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
107.0
29.6
32
*
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.9
29.4
98
202
ZXA00
NOMESCO Finland
Right side
1.3
29.3
2274
18023
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
29.2
28
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
+∞
29.2
28
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.9
28.9
180
627
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
292.8
28.8
29
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
9.4
28.5
59
63
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
9.0
28.3
60
67
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
11.3
28.2
53
47
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
4.1
28.2
111
271
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
28.2
431
2323
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
28.1
27
*
L01EA02
ATC
dasatinib; oral
+∞
28.1
27
*
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
28.1
27
*
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
28.1
27
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
27.9
596
3580
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
64.2
27.9
32
5
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
27.8
541
3160
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.2
27.8
150
475
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
77.8
27.7
31
*
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
10.4
27.6
54
52
SPAT1088
SPAT
Blood transfusion
5.4
27.3
83
155
HA1AA
NOMESCO Finland
X-ray mammography
1.8
27.2
512
2957
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.9
27.2
90
185
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.3
27.1
264
1179
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
27.1
1390
10251
ZXA05
NOMESCO Finland
Left side
1.3
27.1
2109
16688
1DB06
NOMESCO Finland
NA
+∞
27.1
26
*
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
27.1
26
*
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
27.1
26
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.6
26.7
194
744
A04AA55
ATC
palonosetron, combinations; systemic
2.5
26.7
215
874
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
26.6
1798
13902
J01FF01
ATC
clindamycin; systemic
1.3
26.6
2068
16356
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
4.6
26.4
92
200
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
26.3
245
1073
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
4.3
26.1
99
234
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
26.0
25
*
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
26.0
25
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
26.0
25
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
26.0
467
2659
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
25.9
1296
9505
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
8.9
25.8
55
62
B02
ICPC
Lymph gland(s) enlarged/painful
5.2
25.8
81
157
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
15.6
25.8
42
27
602
Kela drug reimbursment
Children's severe malnutrition
11.5
25.8
48
42
WX892
NOMESCO Finland
Monitored bed care
1.6
25.8
642
4025
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.0
25.7
331
1673
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
135.3
25.6
27
*
ZX080
NOMESCO Finland
Image guided radiotherapy
2.6
25.5
192
751
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
4.2
25.3
98
236
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
12.6
25.2
45
36
2301
FHL
Lumbar puncture in anesthesia or operating room
50.1
25.2
30
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
25.2
2559
21003
JAH01
NOMESCO Finland
Laparoscopy
2.1
25.0
296
1443
9652/3-C77.8
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions
+∞
25.0
24
*
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
25.0
24
*
C96.2
ICD-10 Finland
Malignant mast cell tumour
+∞
25.0
24
*
9109
FHL
Other measure in this category
12.2
24.9
45
37
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.5
24.9
118
339
KA1FN
NOMESCO Finland
Isotope renography
4.8
24.8
83
173
JAH00
NOMESCO Finland
Laparotomy
2.3
24.6
236
1048
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
24.6
305
1519
L03AA04
ATC
NA
9.5
24.4
50
53
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
11.6
24.3
45
39
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.2
24.3
132
421
1AA01
NOMESCO Finland
NA
14.2
24.3
41
29
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
5.8
24.0
68
117
5BA03
NOMESCO Finland
NA
56.1
24.0
28
5
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
24.0
23
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
24.0
23
*
C88.7
ICD-10 Finland
Other malignant immunoproliferative diseases
+∞
24.0
23
*
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
24.0
23
*
9652/3-C77.0
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck
+∞
24.0
23
*
C84.1
ICD-10 Finland
Sézary disease
+∞
24.0
23
*
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
24.0
23
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
23.9
484
2859
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
20.7
23.8
35
17
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
6.8
23.7
60
89
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
240.5
23.6
24
*
9650/3-C77.9
ICD-O-3
Hodgkin lymphoma, NOS, of lymph node, NOS
240.5
23.6
24
*
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
240.5
23.6
24
*
2AA01
NOMESCO Finland
NA
87.0
23.6
26
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.4
23.6
115
338
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
23.6
415
2344
AAA10
NOMESCO Finland
Biopsy through craniotomy
15.9
23.6
38
24
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
4.8
23.2
78
164
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
23.1
708
4677
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.2
23.1
88
210
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.8
23.0
147
523
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
24.7
23.0
32
13
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.5
23.0
177
703
RS221
NOMESCO Finland
NA
3.0
22.9
138
471
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
22.9
545
3372
L01BB03
ATC
tioguanine; oral
+∞
22.9
22
*
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
22.9
22
*
1BC07
NOMESCO Finland
NA
65.1
22.8
26
*
E85.9
ICD-10 Finland
Amyloidosis, unspecified
8.9
22.7
48
54
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
230.5
22.6
23
*
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
230.5
22.6
23
*
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
22.6
415
2379
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
120.3
22.6
24
*
R50.8
ICD-10 Finland
Other specified fever
5.2
22.5
70
135
R4190
NOMESCO Finland
Nutritional therapy
2.1
22.4
249
1182
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.4
22.4
196
833
D07AB08
ATC
desonide; topical
1.5
22.3
763
5169
H02AB04
ATC
methylprednisolone; systemic
1.4
22.3
1093
7969
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
45.1
22.3
27
6
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
8.6
22.2
48
56
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
22.1
467
2792
JFB00
NOMESCO Finland
Partial resection of small intestine
2.7
22.1
154
578
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
21.9
21
*
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
21.9
21
*
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
+∞
21.9
21
*
B34.9
ICD-10 Finland
Viral infection, unspecified
2.3
21.7
197
852
E85.89
ICD-10 Finland
Other amyloidosis
20.1
21.6
32
16
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.1
21.5
254
1237
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
21.5
837
5829
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.8
21.5
138
494
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
21.4
1244
9347
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
21.4
214
969
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.0
21.4
86
216
J94.8
ICD-10 Finland
Other specified pleural conditions
2.6
21.4
160
626
NF3AA
NOMESCO Finland
Femur X-ray examination
2.5
21.3
176
724
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
5.3
21.2
65
124
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
3.9
21.2
87
223
WX882
NOMESCO Finland
High dependency care
2.1
21.2
245
1187
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
20.9
1972
15948
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
20.8
20
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
20.8
20
*
9663/3-C77.1
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes
+∞
20.8
20
*
2014A
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]
+∞
20.8
20
*
2016A
ICD-9 Finland
Hodgkin's disease, Mixed cellularity
+∞
20.8
20
*
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
20.8
20
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
20.8
189
821
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.2
20.7
217
1005
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
20.6
836
5870
M87.3
ICD-10 Finland
Other secondary osteonecrosis
22.4
20.3
29
13
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
5.1
20.3
64
126
H26.3
ICD-10 Finland
Drug-induced cataract
4.5
20.3
72
161
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
20.3
526
3333
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
20.2
346
1941
B99
ICPC
Blood/lymph/spleen disease other
5.1
20.2
64
127
Z3226
NOMESCO Finland
Physiotherapist
1.3
20.0
1407
10901
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.1
19.9
114
376
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
18.8
19.9
30
16
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
18.8
19.9
30
16
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.8
19
*
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
+∞
19.8
19
*
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
19.8
19
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
19.8
19
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
29.0
19.6
26
9
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
105.2
19.6
21
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
200.3
19.6
20
*
C96.7
ICD-10 Finland
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
200.3
19.6
20
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
19.5
389
2287
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
24.6
19.5
27
11
CAA30
NOMESCO Finland
Biopsy of orbit
19.4
19.4
29
15
R06.0
ICD-10 Finland
Dyspnoea
1.3
19.4
1934
15734
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.1
19.4
109
358
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.2
19.4
74
178
M05BX04
ATC
denosumab; parenteral
1.7
19.3
382
2241
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.3
19.3
98
299
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.2
19.3
197
904
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.3
19.2
97
295
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
7.6
19.0
44
58
WX720
NOMESCO Finland
Own respiration
1.9
18.9
293
1588
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
18.7
18
*
9659/3-C77.3
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm
+∞
18.7
18
*
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
18.7
18
*
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
18.7
18
*
2AX05
NOMESCO Finland
NA
70.0
18.7
21
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
70.0
18.7
21
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
18.7
201
946
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
8.0
18.7
42
53
J12.8
ICD-10 Finland
Other viral pneumonia
3.6
18.6
83
229
V03AF03
ATC
calcium folinate; systemic
8.2
18.6
41
50
122
Kela drug reimbursment
Aplastic anaemia
14.1
18.5
31
22
WF099
NOMESCO Finland
Other radiotherapy
4.2
18.5
71
172
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.6
18.4
467
2943
B01AB04
ATC
dalteparin; parenteral
1.7
18.3
386
2314
RS220
NOMESCO Finland
NA
2.8
18.2
117
420
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
3.9
18.2
74
189
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.6
18.2
137
540
A03
ICPC
Fever
1.4
18.1
937
6885
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.3
18.1
165
719
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
3.6
18.1
83
235
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
52.6
17.9
21
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.5
17.8
626
4263
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.5
17.8
539
3551
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
17.7
17
*
1XX25
NOMESCO Finland
NA
+∞
17.7
17
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
17.7
17
*
2015A
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]
+∞
17.7
17
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
17.7
17
*
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
17.7
17
*
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
17.7
17
*
D64.8
ICD-10 Finland
Other specified anaemias
2.4
17.7
150
631
WE100
NOMESCO Finland
Profylactic cytostatic therapy
36.7
17.6
22
6
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
95.2
17.5
19
*
TPH00
NOMESCO Finland
Phlebotomy
4.3
17.5
65
153
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.6
17.5
434
2719
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
4.8
17.5
58
122
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.1
17.3
196
943
Z51.0
ICD-10 Finland
Radiotherapy session
2.7
17.3
120
452
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.1
17.3
93
298
ZX196
NOMESCO Finland
NA
42.0
17.3
21
5
KFC00
NOMESCO Finland
Unilateral orchiectomy
3.9
17.1
70
180
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.5
17.1
79
225
ENA10
NOMESCO Finland
Biopsy of pharynx
5.7
17.1
49
87
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
7.4
17.1
40
54
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
31.5
17.0
22
7
SPAT1255
SPAT
Intravenous administration of medicine
1.5
17.0
513
3375
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
6.4
16.9
44
69
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
4.1
16.8
65
159
ZY010
NOMESCO Finland
Hospital outpatient
1.8
16.8
285
1597
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.7
16
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
16.7
16
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
16.7
16
*
170
Kela drug reimbursment
Bosutinib
+∞
16.7
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.7
16
*
9837/3-C42.1
ICD-O-3
Precursor T-cell lymphoblastic leukemia of bone marrow
+∞
16.7
16
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
16.7
16
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
16.7
16
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.7
16.6
366
2218
9690/3-C42.1
ICD-O-3
Follicular lymphoma, NOS, of bone marrow
170.2
16.5
17
*
9831/3-C42.1
ICD-O-3
T-cell large granular lymphocytic leukemia of bone marrow
170.2
16.5
17
*
A06AH03
ATC
naloxegol; oral
2.9
16.5
102
359
GD6AD
NOMESCO Finland
CT of chest and neck
6.1
16.4
44
72
A11CC03
ATC
alfacalcidol; systemic
2.1
16.4
193
942
FM2CE
NOMESCO Finland
NA
5.5
16.4
48
88
I50.9
ICD-10 Finland
Heart failure, unspecified
1.3
16.4
1193
9272
E0000UV
ATC
NA
1.2
16.2
2855
24729
R11
ICD-10 Finland
Nausea and vomiting
1.5
16.2
555
3760
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.6
16.2
377
2323
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.2
16.2
162
738
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.6
16.0
428
2736
L57.0
ICD-10 Finland
Actinic keratosis
1.4
15.9
796
5810
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.7
15.9
105
386
3XA02
NOMESCO Finland
NA
10.0
15.9
31
31
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.6
15.8
54
118
R05
ICD-10 Finland
Cough
1.3
15.7
1383
11035
CFA20
NOMESCO Finland
Biopsy of conjunctiva
6.7
15.7
39
58
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.2
15.7
81
253
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
3.3
15.6
77
232
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
15.6
15
*
9651/3-C77.9
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS
+∞
15.6
15
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
15.6
15
*
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
15.6
15
*
C91.3
ICD-10 Finland
Prolymphocytic leukaemia of B-cell type
+∞
15.6
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.6
15
*
9663/3-C38.3
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of mediastinum, NOS
+∞
15.6
15
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.2
15.6
161
746
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
26.3
15.6
21
8
1DB07
NOMESCO Finland
NA
85.2
15.6
17
*
D73.1
ICD-10 Finland
Hypersplenism
11.7
15.5
28
24
K12.10
ICD-10 Finland
Stomatitis NOS
4.3
15.5
57
134
A46
ICD-10 Finland
Erysipelas
1.3
15.5
1089
8414
TGD00
NOMESCO Finland
Needle biopsy of lung
4.2
15.4
58
139
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.9
15.4
220
1160
A01AB09
ATC
miconazole; local oral
1.5
15.4
632
4445
WX199
NOMESCO Finland
Other local analgesia
1.9
15.2
208
1079
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
6.0
15.2
41
68
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
15.2
372
2325
P01AB01
ATC
metronidazole; oral, rectal
1.2
15.2
2715
23521
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
4.3
15.2
56
132
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
4.0
15.2
60
151
3AA02
NOMESCO Finland
NA
17.7
15.1
23
13
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
15.0
2613
22562
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.6
15.0
106
404
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
11.8
15.0
27
23
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
4.9
15.0
48
98
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.7
14.9
98
359
B01.9
ICD-10 Finland
Varicella without complication
5.1
14.9
46
90
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
14.9
645
4584
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.5
14.9
117
476
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
6.5
14.8
38
59
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
15.0
14.8
24
16
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
6.2
14.8
39
63
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.0
14.8
183
915
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
16.5
14.7
23
14
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.1
14.7
169
821
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
14.7
198
1025
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.2
14.6
141
633
0388X
ICD-9 Finland
Septicaemia, Other specified septicaemias
6.8
14.6
36
53
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.6
14
*
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
+∞
14.6
14
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
14.6
14
*
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
14.6
14
*
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
14.6
331
2029
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
11.8
14.5
26
22
J05AX18
ATC
letermovir; oral
150.2
14.5
15
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.3
14.4
132
579
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.7
14.4
63
173
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.4
14.4
120
502
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.2
14.4
147
676
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
5.0
14.3
45
90
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
1.9
14.3
195
1014
H03AA01
ATC
levothyroxine sodium; systemic
1.3
14.3
1571
12884
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
3.0
14.2
79
261
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
8.6
14.2
30
35
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.4
14.2
118
494
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.5
14.1
449
2990
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.1
14.1
165
810
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
14.1
546
3800
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
14.0
1250
9982
Z94.1
ICD-10 Finland
Heart transplant status
6.0
14.0
38
64
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
3.1
14.0
75
242
6753
FHL
Transabdominal splenectomy
8.4
13.9
30
36
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
3.0
13.9
78
259
D11AH01
ATC
tacrolimus; topical
3.6
13.9
62
174
ZX100
NOMESCO Finland
Oral
2.4
13.8
120
514
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
2.8
13.8
90
327
A04AA03
ATC
tropisetron; systemic
4.8
13.8
45
94
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.2
13.7
140
648
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
6.7
13.7
34
51
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
13.7
1173
9312
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.0
13.6
79
268
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.6
13.6
336
2106
NA2AD
NOMESCO Finland
Thoracic spine CT examination
3.6
13.6
60
167
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
13.5
13
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
13.5
13
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
13.5
13
*
N08.1*C88.0
ICD-10 Finland
Glomerular disorders in Waldenström's macroglobulinaemia
+∞
13.5
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
1.8
13.5
235
1328
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.0
13.5
160
789
3AX16
NOMESCO Finland
NA
140.2
13.4
14
*
PJ002
NOMESCO Finland
Radical radiotherapy of neck, clavicle and axilla
140.2
13.4
14
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.9
13.4
190
1002
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
13.4
140
651
AA1AD
NOMESCO Finland
CT of head and brain
1.2
13.4
1887
15907
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
6.0
13.4
36
60
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.7
13.3
276
1647
D45
ICD-10 Finland
Polycythaemia vera
2.7
13.2
89
333
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
13.8
13.2
22
16
K02.0
ICD-10 Finland
Caries limited to enamel
1.4
13.2
733
5449
L26
ICD-10 Finland
Exfoliative dermatitis
5.0
13.1
41
82
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
13.1
95
370
5AB01
NOMESCO Finland
NA
7.5
13.1
30
40
N19
ICD-10 Finland
Unspecified kidney failure
1.7
13.1
274
1643
A12AA04
ATC
calcium carbonate; oral
2.2
13.1
130
594
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
6.5
13.0
33
51
J01AA02
ATC
doxycycline; systemic
1.2
13.0
6303
59372
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.3
13.0
948
7356
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
4.0
12.9
50
125
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
12.9
277
1674
J02AC05
ATC
isavuconazole; systemic
50.0
12.8
15
*
N18.8
ICD-10 Finland
Other chronic renal failure
1.8
12.7
228
1303
ZZR00
NOMESCO Finland
Flap of skin
1.9
12.7
184
981
Q82.2
ICD-10 Finland
Mastocytosis
9.6
12.7
25
26
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
12.6
891
11251
9731/3-C42.1
ICD-O-3
Plasmacytoma, NOS, of bone marrow
69.9
12.6
14
*
S18
ICPC
Laceration/cut
1.2
12.5
3259
29106
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
3.6
12.5
55
153
L01XE14
ATC
[U] bosutinib; oral
+∞
12.5
12
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
12.5
12
*
20293
ICD-8 Finland
Other neoplasms of lymphoid tissue, Neoplasma benignum sive NUD medullae osseae
+∞
12.5
12
*
5AD01
NOMESCO Finland
NA
+∞
12.5
12
*
C91.5
ICD-10 Finland
Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
+∞
12.5
12
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
9659/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck
+∞
12.5
12
*
C83.41
ICD-10 Finland
Immunoblastic (diffuse)
+∞
12.5
12
*
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
12.5
12
*
C83.7
ICD-10 Finland
Burkitt lymphoma
+∞
12.5
12
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
12.5
12
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
11.0
12.5
23
21
J94.0
ICD-10 Finland
Chylous effusion
17.3
12.5
19
11
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
17.3
12.5
19
11
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
5.7
12.5
35
62
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
12.5
3272
29241
9591/3-C17.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS
130.1
12.4
13
*
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
130.1
12.4
13
*
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
2.3
12.4
110
478
JAL00
NOMESCO Finland
Biopsy of peritoneum
3.9
12.4
49
125
A02BC05
ATC
esomeprazole; systemic
1.2
12.3
2976
26401
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
11.6
12.3
22
19
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.7
12.3
240
1409
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.8
12.2
77
277
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
3.5
12.2
56
162
ELB30
NOMESCO Finland
Excision of submandibular gland
3.6
12.1
54
152
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.6
12.1
41
90
XG410
NOMESCO Finland
Flow-volume spirometry
1.6
12.1
304
1915
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.0
12.1
160
823
A02BA02
ATC
ranitidine; systemic
1.2
12.1
1501
12466
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.8
12.0
49
128
D73.0
ICD-10 Finland
Hyposplenism
26.7
12.0
16
6
J12.2
ICD-10 Finland
Parainfluenza virus pneumonia
18.0
12.0
18
10
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
1.9
12.0
176
942
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.6
12.0
275
1692
XQ848
NOMESCO Finland
Dermatological photography
1.8
12.0
188
1033
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
11.8
554
3996
J01FA06
ATC
roxithromycin; oral
1.2
11.8
2928
26004
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
11.7
11.8
21
18
WW200
SPAT
NA
0.7
11.8
316
4627
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
11.8
332
2153
K02.1
ICD-10 Finland
Caries of dentine
1.2
11.8
3874
35228
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
4.4
11.7
41
93
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.1
11.7
131
632
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
2.7
11.7
79
297
J35.1
ICD-10 Finland
Hypertrophy of tonsils
2.5
11.6
92
377
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.7
11.6
220
1284
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.2
11.6
118
548
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
2.6
11.6
81
310
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
22.9
11.5
16
7
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.4
11.5
462
3237
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
8.1
11.5
25
31
JN4DD
NOMESCO Finland
Scout CT scan of torso
6.5
11.5
29
45
N17.8
ICD-10 Finland
Other acute renal failure
2.5
11.5
89
362
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
4.0
11.5
45
114
GD1LA
NOMESCO Finland
GD
2.2
11.5
117
543
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
3.8
11.5
47
124
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.5
11
*
9670/3-C42.1
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of bone marrow
+∞
11.5
11
*
2002A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma
+∞
11.5
11
*
9695/3-C77.0
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of head, face and neck
+∞
11.5
11
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
9698/3-C77.0
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of head, face and neck
+∞
11.5
11
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
9695/3-C77.4
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg
+∞
11.5
11
*
20399
ICD-8 Finland
Multiple myeloma
+∞
11.5
11
*
L01EM01
ATC
idelalisib; oral
+∞
11.5
11
*
C93.9
ICD-10 Finland
Monocytic leukaemia, unspecified
+∞
11.5
11
*
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
11.5
11
*
9690/3-C77.2
ICD-O-3
Follicular lymphoma, NOS, of intra-abdominal lymph nodes
+∞
11.5
11
*
EMB10
NOMESCO Finland
Tonsillectomy
1.7
11.5
248
1503
D73.9
ICD-10 Finland
Disease of spleen, unspecified
13.6
11.4
19
14
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
2.9
11.4
69
243
9651/3-C77.0
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck
120.1
11.4
12
*
K03.66
ICD-10 Finland
Tooth plaque
1.5
11.3
411
2824
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.2
11.3
108
487
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
11.3
831
6457
1DB01
NOMESCO Finland
NA
35.0
11.2
14
*
B04
ICPC
Blood symptom/complaint
3.9
11.2
44
112
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
2.7
11.2
74
273
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.3
11.2
101
443
SPAT1153
SPAT
Removal of sutures
1.2
11.2
2443
21445
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
5.6
11.1
31
55
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
12.7
11.1
19
15
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
20.0
11.1
16
8
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.0
11.1
62
208
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
2.6
11.0
77
294
B27.0
ICD-10 Finland
Gammaherpesviral mononucleosis
4.4
11.0
38
86
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
3.3
10.9
54
166
ZXE20
NOMESCO Finland
More than three and less than five hours
1.3
10.9
1022
8198
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
7.4
10.9
25
34
B02
ICD-10 Finland
Zoster [herpes zoster]
1.6
10.9
246
1511
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
10.9
277
1755
R53
ICD-10 Finland
Malaise and fatigue
1.2
10.8
1446
12092
NB4AA
NOMESCO Finland
Scapula X-ray examination
4.0
10.8
42
106
5AB14
NOMESCO Finland
NA
6.9
10.8
26
38
L71
ICPC
Malignant neoplasm musculoskeletal
11.9
10.8
19
16
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
3.2
10.8
55
173
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
4.5
10.8
37
83
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.1
10.8
114
539
C07AB07
ATC
bisoprolol; oral
1.2
10.7
3949
36142
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
2.6
10.7
75
288
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.4
10.6
89
377
A32.7
ICD-10 Finland
Listerial sepsis
12.9
10.6
18
14
5609
FHL
Other measure in this category
60.0
10.6
12
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
60.0
10.6
12
*
RD210
NOMESCO Finland
NA
2.1
10.6
120
585
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
4.1
10.5
40
99
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
4.2
10.5
38
90
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.9
10.5
145
762
3AF07
NOMESCO Finland
NA
110.1
10.4
11
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
110.1
10.4
11
*
2089X
ICD-9 Finland
Leukaemia of unspecified cell type, Unspecified leukaemia
+∞
10.4
10
*
9689/3-C42.1
ICD-O-3
Splenic marginal zone B-cell lymphoma of bone marrow
+∞
10.4
10
*
9691/3-C77.4
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg
+∞
10.4
10
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
9698/3-C42.1
ICD-O-3
Follicular lymphoma, grade 3 of bone marrow
+∞
10.4
10
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
10.4
10
*
2024A
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Leukaemic reticuloendotheliosis
+∞
10.4
10
*
360
Kela drug reimbursment
Bosutinib
+∞
10.4
10
*
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
10.4
10
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
10.4
10
*
1XC12
NOMESCO Finland
NA
+∞
10.4
10
*
9650/3-C77.8
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
10.4
10
*
9695/3-C42.1
ICD-O-3
Follicular lymphoma, grade 1 of bone marrow
+∞
10.4
10
*
B37.7
ICD-10 Finland
Candidal sepsis
6.1
10.4
27
44
UDC00
NOMESCO Finland
Ear microscopy
1.4
10.4
483
3484
ZXC40
NOMESCO Finland
Use of ultrasound
3.0
10.4
57
190
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
7.7
10.3
23
30
Z51.88
ICD-10 Finland
Other specified medical care
1.9
10.3
138
716
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.0
10.3
125
625
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
32.5
10.3
13
*
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.0
10.3
56
185
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
8.2
10.3
22
27
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
3.1
10.2
54
175
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.9
10.2
155
841
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
10.2
454
3248
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
3.2
10.2
51
159
J04BA02
ATC
dapsone; oral
3.3
10.1
49
149
N46
ICD-10 Finland
Male infertility
3.1
10.1
53
171
WX704
NOMESCO Finland
Intubation
1.4
10.1
450
3223
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.6
10.1
196
3058
R93.7
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
7.9
10.1
22
28
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
5.6
10.1
28
50
DMW00
NOMESCO Finland
Intubation of maxillary antrum
5.6
10.1
28
50
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
4.4
10.1
35
80
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
4.4
10.1
35
80
A02BC03
ATC
lansoprazole; oral
1.2
10.1
2146
18768
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
6.9
10.0
24
35
B07.9
ICD-10 Finland
Verruca simplex
1.7
10.0
196
1158
V03AC03
ATC
deferasirox; oral
14.6
10.0
16
11
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
2.8
9.9
63
229
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.0
9.9
129
665
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
3.6
9.9
43
120
P20
ICPC
Memory disturbance
0.8
9.9
594
7661
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.7
9.9
193
1138
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.7
9.9
195
1155
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
7.6
9.9
22
29
5639
FHL
Other measure in this category
16.7
9.9
15
9
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.5
9.8
359
2472
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.0
9.8
121
609
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
12.2
9.8
17
14
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.8
9.8
176
1013
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
2.7
9.8
66
249
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.3
9.8
618
4693
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.7
9.7
207
1249
WX725
NOMESCO Finland
Noninvasive ventilation
1.5
9.7
304
2025
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.4
9.7
423
3020
1CA02
NOMESCO Finland
NA
55.0
9.6
11
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
2.7
9.6
65
245
ZXC50
NOMESCO Finland
Cryotherapy
1.6
9.6
218
1344
J01FA10
ATC
azithromycin; systemic
1.1
9.6
3913
35969
D11.70
ICD-10 Finland
Gland sublingual
4.1
9.6
36
89
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.6
9.6
253
1618
A28
ICPC
Limited function/disability NOS
1.2
9.5
1165
9642
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
2.7
9.5
62
231
R81
ICPC
Pneumonia
1.6
9.5
217
1340
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.4
9.5
76
317
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.5
9.5
344
2367
A21
ICPC
Risk factor for malignancy
5.4
9.5
27
50
C10AA01
ATC
simvastatin; oral
0.9
9.5
3146
34511
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
1.9
9.4
124
642
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
3.5
9.4
42
121
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
9.4
9
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
9590/3-C77.9
ICD-O-3
Malignant lymphoma, NOS, of lymph node, NOS
+∞
9.4
9
*
2XA04
NOMESCO Finland
NA
+∞
9.4
9
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
9.4
9
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
9.4
9
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
9.4
9
*
1XX45
NOMESCO Finland
NA
+∞
9.4
9
*
373
Kela drug reimbursment
Ponatinib
+∞
9.4
9
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
9.4
9
*
C85
ICD-10 Finland
Other and unspecified types of non-Hodgkin lymphoma
+∞
9.4
9
*
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
9.4
9
*
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
3.5
9.4
41
116
S04
ICPC
Lump/swelling localized
1.3
9.4
565
4261
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
2.7
9.3
60
221
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
2.0
9.3
120
617
N03AX12
ATC
gabapentin; oral
1.3
9.3
999
8140
XX1XW
NOMESCO Finland
Extensive written report from radiologist
1.9
9.3
140
759
H65.2
ICD-10 Finland
Chronic serous otitis media
2.3
9.3
83
363
Z31.8
ICD-10 Finland
Other procreative management
12.3
9.3
16
13
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
21.7
9.3
13
6
A01AB04
ATC
amphotericin B; local oral
1.5
9.3
330
2259
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
9.3
495
3662
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
2.8
9.2
56
200
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.4
9.2
77
328
3AC01
NOMESCO Finland
NA
2.3
9.2
79
340
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
4.0
9.2
35
88
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.0
9.2
118
606
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.1
9.2
103
503
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.4
9.1
76
323
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
3.8
9.1
36
94
4704
FHL
Neck tumor removal
6.2
9.0
23
37
N06DX01
ATC
memantine; oral
0.7
9.0
231
3405
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
5.3
9.0
26
49
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
2.2
9.0
86
389
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
8.9
333
2305
L04.9
ICD-10 Finland
Acute lymphadenitis, unspecified
5.0
8.9
27
54
D61.1
ICD-10 Finland
Drug-induced aplastic anaemia
24.0
8.9
12
5
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.3
8.9
534
4024
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
4.3
8.9
31
72
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.5
8.8
323
2228
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
2.9
8.8
51
176
B03BA03
ATC
hydroxocobalamin; parenteral
1.4
8.8
419
3038
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
1.8
8.7
150
850
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
8.7
2974
26937
104
Kela drug reimbursment
Thyroid insufficiency
1.4
8.7
453
3337
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
8.7
736
5827
1AB02
NOMESCO Finland
NA
50.0
8.7
10
*
9670/3-C80.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site
50.0
8.7
10
*
XX2XW
NOMESCO Finland
Other teleradiological consultation
3.3
8.7
41
124
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
1.6
8.7
190
1162
M05BA04
ATC
alendronic acid; oral
1.3
8.6
574
4396
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
2.6
8.6
59
225
R59
ICD-10 Finland
Enlarged lymph nodes
7.6
8.6
19
25
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
3.4
8.6
39
114
J01.4
ICD-10 Finland
Acute pansinusitis
2.9
8.6
50
173
TQW80
NOMESCO Finland
Local dermatologic skincare
1.7
8.6
169
1002
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
5.0
8.6
26
52
C10AA07
ATC
rosuvastatin; oral
0.8
8.6
1305
15235
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
5.8
8.6
23
40
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
5.5
8.6
24
44
V03AG01
ATC
sodium cellulose phosphate; systemic
8.2
8.6
18
22
0539X
ICD-9 Finland
Herpes zoster without mention of complication
9.0
8.5
17
19
5701
FHL
Local exploration of lymph nodes (includes biopsy)
10.0
8.5
16
16
WVA20
NOMESCO Finland
Medicine administration
1.8
8.5
139
780
WNF00
NOMESCO Finland
Infection source and contact determination
3.1
8.5
43
137
N06DA03
ATC
rivastigmine; oral, transdermal
0.6
8.4
112
1900
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
90.1
8.4
9
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
90.1
8.4
9
*
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.8
8.4
447
5860
B28
ICPC
Limited function/disability (B)
3.0
8.4
46
155
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
3.1
8.4
44
144
E87.5
ICD-10 Finland
Hyperkalaemia
1.9
8.4
124
672
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
4.2
8.3
30
72
9651/3-C77.8
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions
+∞
8.3
8
*
A81.2
ICD-10 Finland
Progressive multifocal leukoencephalopathy
+∞
8.3
8
*
GA5DA
NOMESCO Finland
Bilateral rib X-ray exmaination
+∞
8.3
8
*
C83.4
ICD-10 Finland
Immunoblastic (diffuse) non-Hodgkin's lymphoma
+∞
8.3
8
*
1XC15
NOMESCO Finland
NA
+∞
8.3
8
*
L01EA04
ATC
bosutinib; oral
+∞
8.3
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
8.3
8
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
8.3
8
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
8.3
8
*
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.3
8
*
C84
ICD-10 Finland
Mature T/NK-cell lymphomas
+∞
8.3
8
*
C94.4
ICD-10 Finland
Acute panmyelosis with myelofibrosis
+∞
8.3
8
*
C92
ICD-10 Finland
Myeloid leukaemia
+∞
8.3
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.3
8
*
9591/3-C07.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of parotid gland
+∞
8.3
8
*
9591/3-C44.5
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of skin of trunk
+∞
8.3
8
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
9695/3-C77.2
ICD-O-3
Follicular lymphoma, grade 1 of intra-abdominal lymph nodes
+∞
8.3
8
*
C94.2
ICD-10 Finland
Acute megakaryoblastic leukaemia
+∞
8.3
8
*
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
2.5
8.3
59
233
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
10.7
8.3
15
14
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
5.8
8.3
22
38
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
3.2
8.3
41
129
Z94.0
ICD-10 Finland
Kidney transplant status
2.2
8.3
79
361
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
3.4
8.2
37
108
K08.3
ICD-10 Finland
Retained dental root
1.4
8.2
455
3387
K11.70
ICD-10 Finland
Hypoptyalism
3.1
8.2
42
135
5702
FHL
Local lymph node removal (eg armpit, groin)
3.5
8.2
36
103
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
3.2
8.2
41
130
D07AC01
ATC
betamethasone; topical
1.2
8.1
2428
21755
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
2.9
8.1
45
153
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
6.0
8.1
21
35
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
3.5
8.1
36
104
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
1.8
8.1
128
710
L01XX35
ATC
anagrelide; oral
5.4
8.1
23
43
134
Kela drug reimbursment
General erythroderma
3.5
8.1
35
99
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
3.1
8.1
41
131
5604
FHL
Vascular preparation or cannulation in the operating room
4.3
8.1
28
65
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.2
8.1
992
8209
Z92.3
ICD-10 Finland
Personal history of irradiation
33.4
8.1
10
*
D73.8
ICD-10 Finland
Other diseases of spleen
17.2
8.1
12
7
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
17.2
8.1
12
7
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
11.7
8.1
14
12
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.5
8.0
272
1845
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.8
8.0
48
171
L01XE18
ATC
[U] ruxolitinib; oral
8.9
8.0
16
18
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
8.9
8.0
16
18
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
2.7
8.0
52
195
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.5
7.9
241
1599
N18.0
ICD-10 Finland
End-stage renal disease
2.1
7.9
89
436
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.6
7.9
142
2248
R60.0
ICD-10 Finland
Localized oedema
1.3
7.9
775
6247
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
0.7
7.9
202
2975
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.1
7.8
81
384
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.2
7.8
73
330
D07AA02
ATC
hydrocortisone; topical
1.3
7.8
827
6731
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
7.8
698
5566
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.6
7.8
191
1205
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
3.0
7.8
41
135
R04.0
ICD-10 Finland
Epistaxis
1.3
7.8
518
3971
N03AX14
ATC
levetiracetam; systemic
1.7
7.7
164
996
D53.1
ICD-10 Finland
Other megaloblastic anaemias, not elsewhere classified
4.0
7.7
29
73
ZXA10
NOMESCO Finland
Bilateral
1.2
7.7
1337
11449
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
3.9
7.7
30
78
20013
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)
45.0
7.7
9
*
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
5.5
7.6
21
38
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
2.9
7.6
42
143
XX1AD
NOMESCO Finland
Other CT-examination
2.7
7.6
50
189
K00.29
ICD-10 Finland
Other or indefinite deviation in the shape or size of the teeth
18.3
7.6
11
6
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.4
7.6
369
2690
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
2.8
7.6
45
160
KA3EB
NOMESCO Finland
Antegrade pyelography
3.0
7.6
41
138
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
2.6
7.6
50
190
D70.81
ICD-10 Finland
Neutropenia congenital
11.8
7.6
13
11
B02.7
ICD-10 Finland
Disseminated zoster
11.8
7.6
13
11
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
11.8
7.6
13
11
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.6
7.6
172
1064
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
3.6
7.5
32
90
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
6.1
7.5
19
31
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
2.0
7.5
90
452
R22.7
ICD-10 Finland
Localized swelling, mass and lump, multiple sites
5.4
7.5
21
39
Z01.2
ICD-10 Finland
Dental examination
1.1
7.5
2655
24055
N91.1
ICD-10 Finland
Secondary amenorrhoea
2.7
7.5
48
177
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
2.9
7.5
43
148
N06DA02
ATC
donepezil; oral
0.7
7.5
199
2911
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
7.1
7.5
17
24
G53.0
ICD-10 Finland
Postzoster neuralgia
2.5
7.4
53
210
OAA41
NOMESCO Finland
Health check based on individual needs
4.8
7.4
23
48
L03AB04
ATC
interferon alfa-2a; parenteral
4.4
7.4
25
57
D72.0
ICD-10 Finland
Genetic anomalies of leukocytes
80.1
7.4
8
*
B01.8
ICD-10 Finland
Varicella with other complications
13.3
7.4
12
9
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
7.6
7.4
16
21
B37.08
ICD-10 Finland
Other candidal stomatitis
2.5
7.4
52
205
7842A
ICD-9 Finland
Symptoms involving head and neck, Swelling, mass, or lump in head and neck
5.9
7.4
19
32
J01MA01
ATC
ofloxacin; systemic
1.3
7.3
614
4854
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.4
7.3
285
1996
A41.4
ICD-10 Finland
Sepsis due to anaerobes
3.6
7.3
31
87
ZXD20
NOMESCO Finland
Day surgery
1.2
7.3
814
6667
I50.1
ICD-10 Finland
Left ventricular failure
1.4
7.3
354
2581
9687/3-C77.9
ICD-O-3
Burkitt lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
9659/3-C77.4
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
9690/3-C44.9
ICD-O-3
Follicular lymphoma, NOS, of skin, NOS
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
C94.1
ICD-10 Finland
Chronic erythremia
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
L01XE24
ATC
[U] ponatinib; oral
+∞
7.3
7
*
9836/3-C42.1
ICD-O-3
Precursor B-cell lymphoblastic leukemia of bone marrow
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
9680/3-C25.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pancreas, NOS
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
9691/3-C77.2
ICD-O-3
Follicular lymphoma, grade 2 of intra-abdominal lymph nodes
+∞
7.3
7
*
PJ023
NOMESCO Finland
Adjuvant radiotherapy of mediastinal lymphnodes
+∞
7.3
7
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
7.3
7
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
C84.2
ICD-10 Finland
T-zone lymphoma
+∞
7.3
7
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
7.3
7
*
2014X
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]
+∞
7.3
7
*
9688/3-C77.9
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS
+∞
7.3
7
*
C84.3
ICD-10 Finland
Lymphoepithelioid lymphoma
+∞
7.3
7
*
2017X
ICD-9 Finland
Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
9823/3-C77.0
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck
+∞
7.3
7
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
9688/3-C77.8
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
RK230
NOMESCO Finland
NA
10.8
7.3
13
12
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
9.3
7.3
14
15
A07AA12
ATC
fidaxomicin; oral
9.3
7.3
14
15
ZXC95
NOMESCO Finland
Use of surgical navigator
2.1
7.3
74
348
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
4.0
7.2
27
68
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.3
7.2
477
3649
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
4.5
7.2
24
54
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
2.7
7.2
47
177
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.1
7.2
76
364
ZX198
NOMESCO Finland
Other local administration
2.1
7.2
78
376
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
1.9
7.1
100
534
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
2.6
7.1
48
185
B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
30.0
7.1
9
*
1XX08
NOMESCO Finland
NA
30.0
7.1
9
*
L04AX01
ATC
azathioprine; systemic
1.5
7.1
255
1755
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.1
7.1
80
391
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.6
7.1
179
1139
EB1WA
NOMESCO Finland
NA
2.6
7.1
47
179
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
2.1
7.1
73
345
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.4
7.1
382
2833
Z3229
NOMESCO Finland
Other healthcare associate professional
1.3
7.1
587
4640
NG1CM
NOMESCO Finland
Knee and lower leg MRI extensive examination with 3 Tesla magnet
6.0
7.1
18
30
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
2.5
7.0
53
216
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
2.3
7.0
60
262
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
2.9
7.0
41
144
J47
ICD-10 Finland
Bronchiectasis
1.8
7.0
120
684
L04AA10
ATC
sirolimus; oral
10.0
7.0
13
13
A02BX02
ATC
sucralfate; oral
1.4
7.0
282
1985
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.4
7.0
300
2142
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
1.9
7.0
90
466
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.7
6.9
28
76
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
1.7
6.9
147
894
DAB10
NOMESCO Finland
Partial excision of auricle
2.8
6.9
42
153
IEP02
NOMESCO Finland
Child-centred family therapy
5.4
6.9
19
35
E28.3
ICD-10 Finland
Primary ovarian failure
5.4
6.9
19
35
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
3.2
6.9
34
108
IEP04
NOMESCO Finland
Focused parenting intervention
13.8
6.9
11
8
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
13.8
6.9
11
8
ECB20
NOMESCO Finland
Oral alveoplasty
2.2
6.8
64
293
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
10.9
6.8
12
11
L98.6
ICD-10 Finland
Other infiltrative disorders of skin and subcutaneous tissue
10.9
6.8
12
11
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.3
6.8
479
3705
E85.0
ICD-10 Finland
Non-neuropathic heredofamilial amyloidosis
40.0
6.8
8
*
9591/3-C34.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lung, NOS
40.0
6.8
8
*
B02.8
ICD-10 Finland
Zoster with other complications
2.6
6.7
45
173
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
2.8
6.7
40
143
PJD99
NOMESCO Finland
Excision of other lymph nodes
5.3
6.7
19
36
174
Kela drug reimbursment
Ruxolitinib
5.6
6.7
18
32
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
6.7
689
5589
K02.9
ICD-10 Finland
Dental caries, unspecified
1.9
6.7
92
487
EP1AE
SPAT
NA
2.3
6.7
58
256
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
7.1
6.7
15
21
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
2.0
6.7
79
395
WX1DM
NOMESCO Finland
Very extensive total body MRI with 3 Tesla magnet
22.5
6.7
9
*
R13
ICD-10 Finland
Dysphagia
1.3
6.7
421
3204
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
2.8
6.7
39
138
WW400
NOMESCO Finland
Plasmaferesis
4.4
6.6
22
50
L04AA05
ATC
[U] tacrolimus; systemic
6.4
6.6
16
25
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
1.7
6.6
134
805
TK810
NOMESCO Finland
Hemofiltration
2.5
6.6
50
204
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.4
6.6
337
2482
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
2.7
6.6
40
146
L41.8
ICD-10 Finland
Other parapsoriasis
8.7
6.5
13
15
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.4
6.5
277
1974
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
10.0
6.5
12
12
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
2.8
6.5
39
141
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.6
6.5
174
1126
B00.11
ICD-10 Finland
Herpes simplex labialis
2.1
6.5
66
310
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
1.8
6.5
95
518
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.5
6.5
46
182
A01AB10
ATC
natamycin; local oral
1.6
6.5
169
1088
I88.8
ICD-10 Finland
Other nonspecific lymphadenitis
5.0
6.5
19
38
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.8
6.5
533
6614
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
3.2
6.5
31
97
TFJ02
NOMESCO Finland
Muscle biopsy of heart
4.5
6.4
21
47
B02.0
ICD-10 Finland
Zoster encephalitis
5.3
6.4
18
34
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
5.7
6.4
17
30
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.6
6.4
139
851
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.1
6.4
66
314
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
2.5
6.4
47
191
4AA04
NOMESCO Finland
NA
69.9
6.4
7
*
JM1AT
NOMESCO Finland
Cytology of spleen with ultrasound guidance
69.9
6.4
7
*
G63.1
ICD-10 Finland
Polyneuropathy in neoplastic disease
69.9
6.4
7
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
69.9
6.4
7
*
PJ043
NOMESCO Finland
Adjuvant radiotherapy of retroperitoneal and mesenterial lymphnodes
69.9
6.4
7
*
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
69.9
6.4
7
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
2.5
6.4
44
173
J45
ICD-10 Finland
Asthma
0.8
6.4
336
4409
ZX197
NOMESCO Finland
NA
7.4
6.4
14
19
L41.4
ICD-10 Finland
Large plaque parapsoriasis
14.3
6.4
10
7
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.3
6.4
393
2983
E29.1
ICD-10 Finland
Testicular hypofunction
2.2
6.4
61
283
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.5
6.4
192
1276
JFB30
NOMESCO Finland
Right hemicolectomy
1.8
6.3
101
565
F03
ICD-10 Finland
Unspecified dementia
0.7
6.3
145
2180
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.0
6.3
77
393
WYA20
NOMESCO Finland
Home visit
1.8
6.3
105
597
NFA20
NOMESCO Finland
Exploration of hip joint or femur
6.5
6.3
15
23
EL3AT
NOMESCO Finland
Salivary gland biopsy with ultrasound guidance
8.1
6.3
13
16
UJD02
NOMESCO Finland
Gastroscopy
1.4
6.3
318
2338
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
9.2
6.3
12
13
A41.2
ICD-10 Finland
Sepsis due to unspecified staphylococcus
4.6
6.3
20
44
20700
ICD-8 Finland
Other and unspecified leukaemia, Leukaemia, acute
+∞
6.2
6
*
C96.1
ICD-10 Finland
Malignant histiocytosis
+∞
6.2
6
*
9691/3-C09.9
ICD-O-3
Follicular lymphoma, grade 2 of tonsil, NOS
+∞
6.2
6
*
9591/3-C73.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of thyroid gland
+∞
6.2
6
*
C88.3
ICD-10 Finland
Immunoproliferative small intestinal disease
+∞
6.2
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.2
6
*
9590/3-C80.9
ICD-O-3
Malignant lymphoma, NOS, of unknown primary site
+∞
6.2
6
*
2029X
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
+∞
6.2
6
*
L01XB01
ATC
procarbazine; oral
+∞
6.2
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.2
6
*
C779, 9715, 3
ICD-O-3
NA
+∞
6.2
6
*
9690/3-C77.3
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of axilla or arm
+∞
6.2
6
*
1AA03
NOMESCO Finland
NA
+∞
6.2
6
*
1XC0R
NOMESCO Finland
NA
+∞
6.2
6
*
9733/3-C42.1
ICD-O-3
Plasma cell leukemia of bone marrow
+∞
6.2
6
*
9680/3-C06.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mouth, NOS
+∞
6.2
6
*
9691/3-C17.9
ICD-O-3
Follicular lymphoma, grade 2 of small intestine, NOS
+∞
6.2
6
*
9698/3-C77.4
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg
+∞
6.2
6
*
1AD01
NOMESCO Finland
NA
+∞
6.2
6
*
9597/3-C44.9
ICD-O-3
Primary cutaneous follicle center lymphoma of skin, NOS
+∞
6.2
6
*
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
3.7
6.2
25
68
J01FA15
ATC
telithromycin; oral
1.3
6.2
567
4537
PJ003
NOMESCO Finland
Adjuvant radiotherapy of neck, clavicle and axilla
26.7
6.2
8
*
WX1CM
NOMESCO Finland
Extensive total body MRI with 3 Tesla magnet
26.7
6.2
8
*
RK224
NOMESCO Finland
NA
26.7
6.2
8
*
C41.40
ICD-10 Finland
Pelvic bones, sacrum and coccyx
26.7
6.2
8
*
D76.3
ICD-10 Finland
Other histiocytosis syndromes
26.7
6.2
8
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
26.7
6.2
8
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
2.4
6.2
48
200
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
2.1
6.2
65
314
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
3.2
6.2
30
95
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.5
6.2
56
1045
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
3.0
6.2
33
112
SPAT1053
SPAT
Memory test
0.8
6.2
875
10291
RS222
NOMESCO Finland
NA
1.9
6.2
82
433
7901A
ICD-9 Finland
Nonspecific findings on examination of blood, Elevated sedimentation rate
5.0
6.2
18
36
WX702
NOMESCO Finland
Supraglottic ventilation device
1.4
6.1
295
2152
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.5
6.1
173
1135
374
Kela drug reimbursment
Ruxolitinib
5.7
6.1
16
28
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.9
6.1
1226
14017
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
1.8
6.1
88
479
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
6.1
1138
9804
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
1.8
6.1
95
527
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
6.1
659
5378
B02AA02
ATC
tranexamic acid; systemic
1.2
6.1
727
6000
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
1.5
6.1
192
1293
K01.0
ICD-10 Finland
Embedded teeth
1.9
6.1
77
400
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.2
6.1
670
5482
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.7
6.1
122
736
D70
ICD-10 Finland
Agranulocytosis
10.0
6.0
11
11
Z94.2
ICD-10 Finland
Lung transplant status
4.4
6.0
20
46
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.3
6.0
437
3398

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
387
423
9.47
321.47
1.3
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
8454
65083
2.65
318.22
21.4
7.3
u/l
82.0
80.1
3.15
8297
60937
(3013115) Eosinophils [#/volume] in Blood
7992
42457
4.90
307.65
14.8
5.6
e9/l
0.2
0.2
37.53
7373
36676
(3006315) Basophils [#/volume] in Blood
7908
41165
4.93
307.65
13.3
5.4
e9/l
0.0
0.0
0.04
7235
35011
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
397
378
10.88
307.65
4.0
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
1050
571
20.36
307.65
1.3
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
780
284
29.63
307.65
3.1
2.4
%
33.9
39.7
2.99
269
97
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
1088
2344
5.07
307.65
8.8
1.5
g/l
0.0
0.0
0.88
1028
2087
(3012095) Magnesium [Moles/volume] in Serum or Plasma
3772
14137
3.63
307.65
7.2
3.2
mmol/l
0.8
0.8
1.68
3631
13099
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1420
1008
16.17
307.65
3.3
3.0
u/ml
9225.8
426.2
1.20
126
53
(44790047)
649
864
7.95
307.65
2.0
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
941
1214
8.43
307.65
1.3
1.3
u/ml
267.2
274.5
0.24
560
742
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
7057
43993
2.91
307.65
17.0
6.5
mmol/l
1.2
1.2
5.54
6001
36870
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
847
419
21.93
307.65
3.4
2.2
e6/l
443.3
652.7
6.19
323
163
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
950
392
26.59
307.65
2.5
1.9
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
1224
541
25.53
307.65
3.1
2.1
e9/l
1.1
1.1
0.70
810
327
(40760892) CBC W Ordered Manual Differential panel - Blood
3792
16791
2.99
307.65
11.7
4.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
3083
7324
5.57
307.65
9.1
1.8
g/l
65.9
66.3
1.16
2965
6511
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6480
9503
16.61
307.65
10.2
3.1
u/l
255.7
242.2
3.82
6323
8872
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
331
174
19.62
307.65
4.6
2.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1520
3135
5.51
307.65
8.7
1.4
g/l
3.1
3.1
0.13
1150
2419
(3048879) Bone marrow aspiration report
398
192
21.52
307.65
2.8
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
621
797
8.23
307.65
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
397
378
10.88
307.65
4.1
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1493
3134
5.40
307.65
8.6
1.4
g/l
10.3
10.3
0.14
1271
2600
(3017354) Segmented neutrophils/100 leukocytes in Blood
752
777
10.36
307.65
6.2
2.6
%
49.0
61.1
18.20
493
502
(40765096) Chromosome analysis panel by Banding
597
118
53.63
307.65
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
718
797
9.61
307.65
3.1
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
3830
5287
10.92
307.65
5.6
2.2
g/l
9.6
10.7
16.67
3658
4774
(3018418) pH of Serum or Plasma
4741
25836
2.54
307.65
11.8
3.8
ph
7.4
7.4
1.32
1100
4900
(3026493) Urate [Moles/volume] in Serum or Plasma
5870
22099
4.84
307.65
6.9
2.5
umol/l
1586.5
5521.5
15.18
5638
18695
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
568
653
9.15
307.65
3.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
2962
6791
5.71
307.65
8.0
3.5
%
0.9
1.0
0.16
1876
1733
(3025159) Blasts/100 leukocytes in Blood
2330
6127
4.62
307.65
8.1
3.6
%
0.6
0.2
1.97
1413
1377
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
765
1135
7.20
307.65
2.0
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
860
1442
6.41
307.65
1.8
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
1574
2014
9.04
307.65
11.2
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
660
1148
6.07
307.65
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
3488
7671
6.35
307.65
5.4
2.2
e9/l
67.0
68.8
1.66
2847
5799
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1647
3358
5.65
307.65
8.3
1.4
g/l
7.1
7.5
10.42
1225
2465
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
236
39
61.90
307.65
1.1
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
1843
2747
7.95
307.65
12.0
1.5
mg/l
164.3
49.1
2.15
1567
2191
(3027945) Reticulocytes/100 erythrocytes in Blood
4102
10263
5.97
307.65
5.4
2.2
%
1.7
1.8
0.69
3874
8928
(3008757) Leukocyte morphology finding [Identifier] in Blood
809
850
10.24
307.65
7.6
3.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
271
40
69.55
307.65
3.5
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
337
148
23.50
307.65
2.7
2.1
e6/l
2185.8
245.1
1.39
163
101
(21494815) CD4 cells/100 lymphocytes in Specimen
1067
488
24.27
307.65
2.5
2.2
%
27.6
43.8
8.66
111
60
(3048929) Epstein Barr virus Ab [Presence] in Serum
1203
1866
7.16
307.65
1.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
518
693
7.82
307.65
1.4
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
3954
7051
8.46
307.65
1.5
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
7932
42025
4.82
307.65
13.5
5.5
e9/l
3.4
1.8
40.81
7369
36381
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1420
319
51.45
307.65
2.3
1.4
mg/l
4.1
4.0
0.09
1349
304
(1175426) CD3 cells/100 lymphocytes in Blood
1006
424
26.18
307.65
2.5
1.9
%
71.3
70.7
0.24
969
404
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1678
1858
10.59
307.65
2.0
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
805
385
22.59
307.65
3.4
2.1
e6/l
605.2
462.5
3.97
682
324
(40758292) HTLV I+II Ab panel - Serum
359
50
74.35
307.65
1.5
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
3531
13960
3.32
307.65
3.4
1.3
g/l
2.3
2.6
3.71
2913
7869
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1879
6372
3.38
307.65
2.4
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
1368
1285
12.12
307.65
1.4
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
1070
2301
5.07
307.65
8.9
1.5
g/l
0.0
0.0
0.00
1028
2078
(40758558) Short blood count panel - Blood
3829
21010
2.31
307.65
20.3
6.3
—
—
—
0
0
(44790048)
649
864
7.95
307.65
2.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
778
1066
7.81
307.65
4.1
1.8
pg
33.7
32.6
8.94
770
1059
(3021440) Promyelocytes/100 leukocytes in Blood
2631
6509
5.08
307.65
8.3
3.5
%
0.2
0.1
1.81
1741
1605
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
255
59
44.29
307.65
1.4
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
630
1104
6.01
307.65
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
371
280
13.71
307.65
4.2
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
1521
2806
6.18
307.65
8.6
1.5
g/l
3.7
0.5
44.86
1310
2356
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
1233
324
43.08
307.65
1.3
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
461
182
26.47
307.65
2.2
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
549
220
26.30
307.65
2.3
1.9
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
997
415
26.48
307.65
2.5
1.9
%
14.3
14.1
0.07
428
188
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
698
729
10.20
307.65
3.1
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
1892
575
40.06
307.65
1.5
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
488
343
14.88
307.65
2.0
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
7783
39520
4.93
307.65
14.8
5.8
%
31.9
26.6
125.83
7579
36399
(3001604) Monocytes [#/volume] in Blood
7891
40936
4.93
307.65
13.3
5.4
e9/l
0.6
0.6
0.67
7220
34781
(42870588) Differential panel, method unspecified - Blood
6597
28510
4.64
307.65
13.8
5.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
5757
36287
2.32
307.65
22.0
9.7
e9/l
0.0
0.0
1.35
4957
29454
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
660
1115
6.25
307.65
1.8
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
204
58
35.86
307.65
1.6
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1346
1865
8.15
307.65
2.8
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
724
540
14.34
307.65
1.4
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
267
118
23.20
307.65
3.3
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
397
378
10.88
307.65
4.0
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
7631
38918
4.68
307.65
13.5
5.6
%
52.5
58.3
168.75
7421
36018
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3353
14819
2.87
307.65
3.1
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
4259
9867
6.64
307.65
1.6
1.7
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
464
203
23.88
307.65
2.6
1.9
%
33.9
26.6
8.24
433
192
(4035726)
3072
7117
5.72
307.65
1.7
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
408
428
9.88
307.65
3.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
8212
47724
4.51
307.65
28.7
8.1
e9/l
3.5
4.3
121.81
7679
41203
(3047189) Immunofixation for 24 hour Urine
636
311
21.73
307.65
2.8
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
779
346
24.27
307.65
3.3
2.2
e9/l
0.6
0.1
2.65
765
331
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1707
1325
15.23
307.65
6.5
5.6
iu/ml
1133.1
1429.8
0.11
297
186
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
747
558
14.35
307.65
2.7
2.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
389
137
29.47
307.65
2.9
1.3
u/l
53.8
28.9
1.03
367
121
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
397
378
10.88
307.65
4.0
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
4957
25136
2.87
307.65
8.6
4.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
556
229
25.60
307.65
2.3
1.9
%
8.4
8.3
0.03
549
220
(3021879) Hepatitis B virus core Ab [Presence] in Serum
3526
4309
11.90
307.65
1.4
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
2892
4198
9.18
307.65
4.0
1.5
g/l
2.0
1.2
11.29
2639
3766
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1659
4213
4.50
307.65
2.3
1.5
g/l
1.4
1.6
5.28
1421
3580
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
582
573
10.70
307.65
1.6
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
368
280
13.59
307.65
4.2
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
368
280
13.59
307.65
4.2
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
7748
38421
5.07
307.65
14.5
5.6
%
2.5
2.9
31.71
7554
35469
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2420
10218
2.79
307.65
2.5
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1362
1927
7.99
307.65
2.7
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1644
3346
5.65
307.65
8.3
1.4
g/l
3.7
3.9
1.04
1140
2373
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1001
2276
4.76
307.65
4.6
2.6
g/l
3.6
3.6
0.69
968
2162
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
1056
1282
9.06
307.65
1.4
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2420
10197
2.79
307.65
2.6
1.7
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
510
728
7.32
307.65
3.0
1.7
g/24h
0.3
1.1
—
10
35
(3015377) Calcium [Moles/volume] in Serum or Plasma
4888
29108
2.29
307.65
6.8
3.2
mmol/l
2.3
2.4
5.78
4497
24898
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1646
3354
5.65
307.65
8.3
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
7764
38645
5.06
307.65
15.2
5.9
%
9.1
8.8
8.18
7569
35810
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
706
1277
5.86
307.65
1.9
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
568
653
9.15
307.65
3.4
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
1162
2640
4.83
307.65
8.5
1.4
g/l
37.3
37.4
0.35
1063
2209
(3003458) Phosphate [Moles/volume] in Serum or Plasma
3369
11637
3.81
307.65
9.7
5.7
mmol/l
1.1
1.0
3.54
3243
10718
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
483
325
15.54
307.65
5.3
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
1605
1694
11.03
307.65
3.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
4098
8271
7.55
307.65
1.6
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1845
2746
7.96
307.65
12.0
1.5
mg/l
79.1
37.4
4.46
1568
2191
(3022096) Basophils/100 leukocytes in Blood
7643
37336
5.02
307.65
14.1
5.7
%
0.6
0.7
1.12
7442
34511
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
6476
40038
2.65
307.65
14.5
6.0
mmol/l
1.2
1.2
6.43
6218
35920
(3006245) CD3-CD19+ cells/100 cells in Blood
461
209
23.04
307.65
2.6
2.1
%
11.7
12.5
0.23
416
195
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1106
3161
3.80
307.65
2.6
2.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1819
2662
8.08
307.65
11.7
1.5
ratio
18.6
2.0
2.21
126
211
(44790049)
649
864
7.95
307.65
2.0
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
1193
1160
11.50
307.65
1.4
1.5
u/ml
114.5
116.6
0.11
295
224
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
784
368
22.97
307.65
3.6
2.2
e9/l
0.2
0.2
0.21
684
323
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2917
14009
2.51
307.65
3.7
2.1
s
29.4
30.1
7.89
2837
13589
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
7691
44392
3.87
307.65
16.3
5.9
umol/l
10.7
12.1
21.50
7558
41961
(3042111) Morphology [Interpretation] in Bone marrow Narrative
2344
995
30.18
307.65
2.2
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
651
937
7.35
307.65
2.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
568
653
9.15
307.65
3.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
978
777
13.80
307.65
4.2
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
2906
5983
6.37
307.65
8.5
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
1349
1281
11.96
307.65
1.4
1.5
u/ml
18.2
18.3
—
9
30
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
288
87
34.02
307.65
4.3
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
393
64
63.79
307.65
1.3
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
701
1154
6.44
307.65
1.7
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
6672
37972
3.14
307.65
9.8
4.7
g/l
34.3
35.0
21.03
6420
34967
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
487
343
14.85
307.65
2.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
1105
1388
8.79
307.65
2.8
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
2581
6183
5.23
307.65
7.9
3.4
%
0.6
0.7
0.60
1334
1262
(44806118)
649
864
7.95
307.65
2.0
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
1192
2499
5.26
307.65
8.5
1.4
g/l
0.1
0.0
2.87
1122
2236
(40768795) Lymph node Pathology biopsy report
1501
473
36.96
307.65
1.4
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
1278
1239
11.63
307.65
6.1
2.7
%
1.3
1.6
1.15
1048
932
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
300
243
12.68
305.87
1.7
2.0
u/ml
2965.6
61496.7
0.84
31
36
(3017817) Protein [Mass] in Urine collected for unspecified duration
486
742
6.82
303.99
4.0
2.0
—
0.4
—
0
5
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
152
16
96.40
292.32
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4454
27114
2.13
290.67
5.9
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1168
3757
3.38
290.56
2.5
1.9
ug/l
2.4
2.0
0.31
1072
3277
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5824
39275
2.11
288.58
8.5
4.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
921
2617
3.77
276.53
1.8
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
628
1359
4.86
270.39
1.3
1.3
u/l
98.5
34.8
7.77
573
1165
(3013707) Erythrocyte sedimentation rate by Westergren method
7921
61027
2.28
266.20
6.9
4.1
mm/h
18.8
13.1
93.69
7593
55813
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
156
37
42.79
261.16
8.8
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
280
266
10.79
257.12
1.3
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
158
42
38.19
257.07
3.6
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2057
9550
2.44
254.40
6.9
2.7
umol/l
7.3
9.3
4.34
1880
8290
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2450
12348
2.29
250.52
2.9
2.6
%
24.0
22.0
7.40
2161
10401
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2980
16266
2.17
250.20
5.0
3.1
mmol/l
2.5
2.5
4.37
2800
14096
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
473
855
5.75
249.34
3.7
2.9
—
—
—
0
0
(3024471) HLA-A [Type]
249
209
12.18
248.11
1.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
213
144
15.08
240.94
1.8
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2532
13157
2.22
238.94
2.8
2.5
g/l
2.2
2.3
23.64
2397
12095
(3024932) HLA-DR beta [Type]
239
205
11.91
234.84
1.4
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
3618
21687
2.03
233.29
7.3
4.0
%
86.8
86.6
0.27
3546
21148
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
540
1174
4.80
230.72
6.7
6.5
mg/l
10.8
11.9
6.02
497
1075
(3022948) Iron [Moles/volume] in Serum or Plasma
2647
14169
2.17
230.71
2.8
2.5
umol/l
13.0
12.5
1.99
2510
13031
(3020779) Urea [Moles/volume] in Serum or Plasma
1839
8496
2.42
227.59
9.8
7.2
mmol/l
10.4
10.5
0.18
1773
8040
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3486
20807
2.02
225.93
5.5
2.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
796
2366
3.56
222.21
4.8
2.4
%
90.4
89.5
0.50
780
2224
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
235
214
11.21
221.98
1.2
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
715
1995
3.78
219.26
1.6
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
2375
12419
2.18
218.03
2.1
2.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
224
196
11.66
217.23
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
333
486
7.05
216.76
2.2
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
6804
51269
1.96
216.50
9.5
4.8
mmol/l
6.6
6.8
11.42
6599
48053
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
698
1986
3.70
207.78
1.2
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
172
106
16.48
204.17
1.5
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
212
189
11.43
203.06
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
5286
37293
1.85
199.04
10.9
10.2
inr
1.2
1.3
3.28
1483
10289
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
178
124
14.59
197.97
1.4
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
660
1921
3.60
189.59
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
344
601
5.89
187.59
1.1
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
101
16
63.74
183.09
14.4
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
100
15
67.31
182.90
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
100
15
67.31
182.90
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
100
15
67.31
182.90
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
100
15
67.31
182.90
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
99
15
66.63
180.77
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
1053
4168
2.70
177.68
1.5
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
249
337
7.55
173.32
1.3
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
357
707
5.19
169.75
2.1
1.4
—
—
—
0
0
(3036603) Volume of Urine
303
533
5.83
163.96
2.8
1.4
ml
1895.3
1875.6
0.06
62
136
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
309
562
5.64
161.39
1.9
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3467
22620
1.80
158.24
2.4
2.3
mg/l
3.2
3.0
5.35
3018
19168
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4709
33601
1.74
156.96
3.7
2.9
ug/l
354.0
143.2
27.95
4417
30603
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
104
36
29.17
156.35
10.7
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
152
121
12.73
156.35
1.8
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
369
807
4.70
156.01
1.2
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
88
16
55.46
155.55
2.6
1.1
mpas
1.9
1.8
—
62
8
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
354
755
4.82
154.28
1.6
1.8
titre
3472.0
1369.7
—
5
33
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
281
492
5.84
152.77
2.0
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
118
61
19.56
152.16
2.1
4.1
mg/l
1.3
1.2
0.02
69
49
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
281
494
5.82
152.12
2.0
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
130
83
15.85
151.43
1.5
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
341
719
4.87
150.64
1.2
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2845
17708
1.84
150.18
2.7
1.7
mg/l
1.9
1.4
4.67
2343
13589
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
650
2171
3.13
149.06
5.2
2.5
%
209.0
198.2
2.17
633
2066
(3002582) Erythrocytes [#/volume] in Urine
3960
27209
1.74
148.75
4.1
3.4
e6/l
36.4
103.0
8.07
3192
21102
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
625
2044
3.19
148.51
1.7
1.9
mg/l
14.2
11.4
2.07
578
1884
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
234
356
6.70
146.33
2.6
5.7
u/ml
40.3
9310.2
—
7
73
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4013
27776
1.73
146.10
3.8
3.1
ng/l
1819.2
1623.4
1.65
3622
23962
(3035933) Granulocytes/100 leukocytes in Blood
165
169
9.91
143.46
1.8
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
668
2344
2.98
140.37
8.1
4.0
mg/l
1.5
1.6
2.26
624
2112
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
470
1342
3.62
138.36
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3658
25001
1.72
137.19
4.0
3.3
e6/l
0.5
0.5
0.07
2895
19017
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1148
5309
2.31
137.03
1.7
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
177
211
8.52
137.02
1.6
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
459
1303
3.64
136.29
2.3
2.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
487
1447
3.48
134.89
1.3
1.3
miu/ml
176.6
215.9
1.00
104
607
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
245
428
5.84
133.47
2.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
245
428
5.84
133.47
2.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
3222
21398
1.73
133.20
1.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4525
32905
1.67
133.19
2.6
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1747
9607
1.98
132.66
2.0
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
4315
31069
1.67
131.41
4.8
3.9
e6/l
122.2
104.4
0.31
3333
22521
(3028433) Virus identified in Specimen by Culture
192
266
7.34
130.85
1.3
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
568
1890
3.12
130.80
3.0
1.3
mg/l
612.7
539.3
1.53
552
1783
(36304419) Bacteria [Presence] in Urine
3519
24044
1.70
130.55
4.0
3.3
—
—
—
0
0
(3036489) Thrombin time
755
2950
2.68
129.37
4.6
2.1
s
22.5
21.7
2.32
717
2618
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1166
5578
2.23
127.86
2.2
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
518
1663
3.23
126.64
3.3
1.3
e6/l
28.8
23.4
0.18
420
1274
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
517
1666
3.21
125.60
3.4
1.4
e6/l
4610.6
1078.6
0.41
429
1349
(3002032) Base excess in Venous blood by calculation
1613
8828
1.98
123.39
7.4
4.0
mmol/l
1.8
1.9
0.10
1330
7135
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
92
45
20.62
121.44
3.0
3.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
482
1522
3.27
121.04
3.4
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1384
7226
2.06
120.63
2.4
2.3
nmol/l
377.5
375.9
0.10
1318
6590
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
67
11
61.30
120.44
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
1474
7888
2.01
119.94
10.0
8.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1606
8863
1.96
119.61
7.4
3.9
kpa
5.7
5.8
3.90
1568
8594
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
279
604
4.72
119.30
2.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
275
591
4.75
118.64
2.3
1.3
—
—
—
0
0
(3012544) pH of Venous blood
1641
9173
1.94
117.50
7.4
4.0
ph
7.4
7.4
0.00
20
44
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1381
7358
2.01
113.31
10.7
3.6
mmol/l
1.2
1.2
0.47
1333
6350
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
790
3364
2.46
112.81
3.6
3.2
u/ml
0.3
0.3
1.11
476
1905
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
114
5
230.51
110.91
1.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
772
3291
2.45
109.90
1.7
1.8
u/l
40.7
38.6
1.78
697
2829
(3026782) Osmolality of Urine
2700
17842
1.69
109.52
3.4
2.9
mosm/kgh2o
540.8
554.8
3.02
2413
15151
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
489
1667
3.03
107.72
3.1
1.2
mmol/l
3.7
3.9
2.99
466
1555
(3000850) Epithelial cells [#/volume] in Urine
2839
19130
1.67
106.37
3.2
2.7
e6/l
4.9
4.8
0.07
2552
16712
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
850
3846
2.32
105.66
4.1
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
650
2648
2.55
101.75
1.7
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
1082
5480
2.09
101.36
3.5
3.1
e9/l
3.9
4.2
1.15
806
4061
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
510
1857
2.84
99.62
2.5
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
1162
6080
2.03
99.51
5.3
4.1
ph
7.4
7.4
1.64
157
734
(3010375) cycloSPORINE [Mass/volume] in Blood
196
367
5.42
99.11
37.1
28.3
ug/l
127.9
111.5
2.83
180
314
(3031040) Bacteria [#/volume] in Urine by Automated count
6739
56182
1.57
98.43
5.6
4.7
e6/l
686.9
1727.8
1.70
132
846
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1169
6155
2.01
98.31
5.3
4.1
kpa
5.0
5.2
6.92
1096
5676
(3025468) Yersinia sp identified in Specimen by Organism specific culture
357
1067
3.43
97.74
3.0
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3601
26144
1.58
97.55
6.1
3.2
u/l
34.5
35.1
0.20
3454
24608
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1128
5881
2.03
97.46
5.3
4.1
mmol/l
1.8
1.7
0.07
899
4331
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
234
519
4.59
97.10
2.8
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
355
1068
3.41
96.19
3.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
356
1073
3.40
96.18
3.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
355
1071
3.40
95.76
3.0
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
325
929
3.58
95.29
1.8
2.1
titre
0.7
2.9
—
7
22
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
354
1070
3.39
95.21
3.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
358
1095
3.35
94.48
3.0
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
290
782
3.79
92.66
1.4
1.4
g/l
2.1
3.0
8.73
209
548
(3024139) IgG subclass 3 [Mass/volume] in Serum
290
782
3.79
92.66
1.4
1.4
g/l
0.3
0.4
5.86
205
550
(3027135) IgG subclass 1 [Mass/volume] in Serum
290
782
3.79
92.66
1.4
1.4
g/l
7.2
6.7
0.49
210
546
(4062490)
290
783
3.78
92.49
1.4
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
926
4579
2.12
92.02
9.6
4.3
mmol/l
24.4
24.1
1.76
860
4103
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
64
26
24.76
90.81
2.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2198
14361
1.67
90.37
3.7
3.1
e6/l
2.2
2.1
0.06
1259
8028
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3648
27028
1.54
87.91
3.1
2.6
u/l
55.1
59.1
2.64
3400
24796
(3007853) Bacteria identified in Skin by Aerobe culture
1670
10192
1.76
87.81
1.9
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
188
382
4.99
86.68
1.8
1.5
ug/l
3.6
4.5
0.38
151
319
(40763480) Human metapneumovirus Ag [Presence] in Specimen
60
24
25.14
85.59
2.0
1.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
786
3751
2.19
85.33
1.2
1.6
u/ml
11.1
18.0
—
8
107
(3014576) Chloride [Moles/volume] in Serum or Plasma
1845
11677
1.71
84.86
10.4
6.9
mmol/l
104.4
104.5
0.30
1798
11436
(3024980) IgG subclass 4 [Mass/volume] in Serum
369
1238
3.05
83.42
1.5
1.6
g/l
0.6
0.8
3.94
269
939
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
744
3532
2.19
81.74
2.5
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
497
1980
2.59
81.20
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
497
1980
2.59
81.20
1.6
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
147
256
5.81
80.35
1.5
1.1
g/l
1.3
0.2
1.76
17
17
(3014111) Lactate [Moles/volume] in Serum or Plasma
1378
8151
1.80
80.03
8.6
6.8
mmol/l
1.4
1.4
0.57
1333
7825
(3016018) Differential panel - Cerebral spinal fluid
272
776
3.57
79.96
3.3
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
382
1342
2.92
79.56
1.6
1.5
g/l
31.8
32.0
0.10
360
1185
(3021960) Folate [Moles/volume] in Serum or Plasma
2957
21284
1.55
79.44
1.8
1.6
nmol/l
19.6
20.1
1.14
2665
18029
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2276
15430
1.61
79.30
3.5
2.9
e6/l
1.1
1.3
0.63
1336
9028
(3009871) Measles virus Ab [Titer] in Serum
124
186
6.74
78.59
1.9
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4322
33729
1.48
78.55
2.5
2.2
nmol/l
78.1
78.3
0.24
3994
29708
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2530
17625
1.58
78.40
4.5
4.0
ng/l
333.3
517.6
1.09
2136
14593
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
91
96
9.55
77.40
1.8
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
91
96
9.55
77.40
1.8
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
91
96
9.55
77.40
1.8
1.1
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
63
37
17.12
76.38
1.6
1.0
u/ml
20990.3
—
—
8
0
(4212803)
79
70
11.36
75.86
1.1
1.0
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
105
137
7.73
75.42
1.5
1.2
titre
41.4
112.9
0.57
18
17
(3025941) Bacteria identified in Stool by Culture
825
4234
2.03
73.61
1.4
1.3
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
51
20
25.62
73.20
2.2
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
56
28
20.10
73.07
2.6
5.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3527
26706
1.49
73.02
3.6
3.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
214
552
3.94
72.83
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
852
4468
1.99
71.46
5.8
4.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
285
901
3.22
71.24
1.3
1.3
u/l
340.3
417.5
0.66
264
851
(3023410) Appearance of Cerebral spinal fluid
248
722
3.49
70.69
5.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
294
964
3.11
69.12
1.4
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
113
176
6.48
69.11
1.3
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
434
1755
2.54
68.64
1.9
1.4
u/l
10.9
9.8
0.86
343
1398
(3019225) pH of Specimen
1446
9039
1.70
68.25
11.0
4.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1568
10067
1.66
66.71
1.3
1.3
titre
586.3
507.6
0.74
293
2115
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1145
6761
1.78
66.08
4.1
4.0
ng/l
89.5
95.0
1.06
991
5724
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4290
34240
1.43
65.18
4.6
3.9
ng/l
54.7
74.6
0.52
3470
25239
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
264
844
3.18
64.78
2.4
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
6705
58049
1.44
64.39
5.4
4.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
748
3902
1.99
63.46
6.3
4.5
mmol/l
25.0
24.8
1.56
708
3585
(3020393) Adenovirus Ag [Presence] in Stool
83
104
8.04
61.70
1.6
1.3
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
100
156
6.46
61.09
7.0
3.9
u/l
46.0
74.7
0.57
20
63
(3012441) Differential panel - Pleural fluid
294
1034
2.90
61.07
1.6
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
600
2928
2.11
61.05
1.5
1.6
titre
300.4
241.8
0.10
12
137
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1492
9656
1.64
61.03
2.8
4.1
ug/l
9.6
25.9
4.42
1121
8005
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1324
8335
1.67
60.29
2.4
2.3
g/l
0.2
0.2
5.16
1217
7716
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
99
155
6.44
60.27
1.7
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
235
736
3.24
59.67
1.4
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
320
1194
2.73
59.48
1.6
1.5
e6/l
2729.8
2575.2
0.08
235
873
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
496
2268
2.25
59.42
1.7
1.5
g/l
0.2
0.2
0.03
457
2140
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
507
2344
2.22
59.13
1.7
1.5
g/l
1.2
1.2
0.69
486
2211
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
43
19
22.72
58.93
4.9
3.6
mg/l
4.1
4.5
0.13
37
11
(3019309) Folate [Moles/volume] in Red Blood Cells
2475
18090
1.48
58.39
1.9
1.8
nmol/l
1175.2
1155.8
0.45
1988
13417
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
97
154
6.35
58.26
1.7
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
223
691
3.28
57.63
1.6
1.4
u/l
16.3
12.5
5.53
214
661
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
974
5708
1.78
57.28
11.0
7.4
mmol/l
24.9
24.8
0.44
964
5656
(40768806) Pleura Pathology biopsy report
290
1051
2.81
56.99
1.6
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
164
419
3.96
56.61
1.2
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
73
87
8.44
56.53
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1425
9289
1.62
56.25
5.3
3.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
337
1334
2.58
55.67
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
292
1083
2.75
54.92
1.6
1.5
e6/l
84437.0
56938.7
0.42
180
643
(3026250) Tacrolimus [Mass/volume] in Blood
140
327
4.33
54.50
27.9
34.1
ug/l
7.7
7.2
0.84
118
292
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
489
2302
2.18
54.49
1.5
1.6
iu/ml
0.9
6.8
1.10
124
529
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
400
1756
2.33
52.73
1.5
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
1617
11019
1.55
52.47
1.4
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1588
10816
1.55
51.56
8.7
7.0
mmol/l
1.2
1.0
1.12
1232
8434
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1591
10863
1.55
51.04
8.6
7.0
kpa
5.0
5.1
3.53
1508
10335
(3023323) Follitropin [Units/volume] in Serum or Plasma
414
1871
2.26
50.96
2.0
1.4
iu/l
22.7
28.1
2.69
330
1568
(3027801) Oxygen [Partial pressure] in Arterial blood
1588
10859
1.55
50.55
8.6
7.0
kpa
12.0
12.1
0.36
1510
10309
(3024354) Oxygen [Partial pressure] in Venous blood
1155
7353
1.64
49.74
7.5
3.4
kpa
4.7
4.5
1.83
1117
7100
(3036782) Glucose [Moles/volume] in Pleural fluid
246
882
2.83
49.35
1.4
1.4
mmol/l
6.2
6.4
0.42
234
798
(3010937) Rubella virus Ab [Presence] in Serum
39
21
18.64
49.12
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
440
2086
2.16
48.12
4.4
3.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
683
3798
1.85
47.47
1.4
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1439
9755
1.55
47.38
9.2
7.4
%
95.3
95.5
0.53
1382
9373
(3023419) Bacteria identified in Sputum by Culture
290
1161
2.54
46.81
2.4
2.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
42
29
14.54
46.74
3.2
5.6
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
210
713
2.99
46.53
1.3
1.3
u/l
21.1
13.1
1.21
194
648
(3028679) Herpes simplex virus Ab [Presence] in Serum
129
320
4.07
46.43
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
601
3249
1.90
45.58
2.3
3.5
u/ml
311.7
2285.2
1.52
484
2795
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
108
237
4.59
45.53
1.7
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
4417
36869
1.35
45.21
2.3
2.1
pmol/l
91.7
94.0
2.55
2688
19216
(3037121) Protein [Mass/volume] in Urine
583
3129
1.91
45.19
2.6
3.2
g/l
0.5
0.3
2.37
324
1352
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
8795
81902
1.50
44.52
40.5
15.4
mg/l
23.7
26.0
10.56
8118
65827
(3024891) Influenza virus A+B Ag [Presence] in Specimen
413
1977
2.13
44.05
1.4
1.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
40
29
13.84
43.31
3.3
5.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
227
848
2.71
42.15
1.1
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
460
2343
2.01
41.50
4.2
4.2
kpa
8.3
8.2
0.92
421
2173
(3027315) Oxygen [Partial pressure] in Blood
430
2141
2.05
41.31
4.9
4.2
kpa
8.5
8.5
0.25
421
2089
(3012501) Base excess in Blood by calculation
428
2129
2.05
41.22
4.9
4.2
mmol/l
2.7
2.6
0.73
318
1447
(3013290) Carbon dioxide [Partial pressure] in Blood
428
2130
2.05
41.17
4.9
4.2
kpa
4.9
5.0
2.04
419
2079
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1189
7960
1.56
40.98
2.8
2.4
u/l
35.7
53.2
0.97
1026
6770
(40767503) Oxygen content in Capillary blood by calculation
407
1993
2.08
40.89
3.1
2.6
%
14.8
16.2
7.32
215
1044
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1296
8875
1.53
40.25
9.9
7.8
g/l
111.4
121.4
52.95
1248
8550
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
285
1215
2.38
40.18
1.2
1.1
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
0.6
1.7
0.92
17
24
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
0.9
2.5
0.93
29
28
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
0.1
1.0
2.16
18
27
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
0.6
1.5
0.79
28
27
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
0.5
1.0
0.51
18
26
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
0.5
2.0
1.21
24
30
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
2.8
2.3
0.17
26
24
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
1.0
4.4
1.78
22
24
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
42
39
10.81
39.05
1.7
1.5
mg/l
0.5
1.9
0.93
23
28
(3010421) pH of Blood
468
2453
1.95
38.87
4.9
4.1
ph
7.4
7.4
3.23
419
2081
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
135
392
3.48
38.77
1.1
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
42
40
10.54
38.38
1.7
1.5
mg/l
0.6
1.4
0.49
21
27
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
298
1323
2.29
38.28
1.2
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
33
21
15.76
38.27
1.1
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
463
2432
1.95
38.21
3.4
3.4
mmol/l
24.3
24.8
1.29
406
2122
(3006922) Hepatitis E virus Ab [Presence] in Serum
154
492
3.16
37.95
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
496
2692
1.88
37.08
4.3
3.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
231
932
2.51
36.74
1.6
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
42
43
9.80
36.49
1.4
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
292
1318
2.25
36.07
1.9
2.2
u/l
6284.3
3636.2
0.49
93
505
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
169
587
2.91
36.03
1.4
1.3
mmol/l
2.4
2.1
0.84
159
552
(3027273) Bicarbonate [Moles/volume] in Venous blood
740
4566
1.67
35.54
4.2
3.5
mmol/l
24.9
25.1
0.78
722
4425
(3021901) Oxygen saturation in Capillary blood
357
1757
2.07
35.39
3.2
3.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
7250
66097
1.32
35.35
45.8
18.8
%
14.5
13.8
233.71
7173
64556
(40757373) Influenza virus identified in Isolate
82
177
4.66
35.35
1.4
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
157
533
2.98
34.88
1.4
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
142
457
3.14
34.60
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
142
459
3.12
34.35
1.1
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
123
366
3.39
34.06
1.9
1.2
%
56.5
61.2
0.21
22
41
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
133
417
3.22
33.86
1.2
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
91
226
4.05
32.80
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
176
661
2.69
32.43
1.7
1.4
nmol/l
0.3
0.3
0.20
146
496
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
128
403
3.20
32.38
1.5
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
863
5671
1.57
31.93
6.2
3.4
g/l
116.3
128.8
44.91
843
5521
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
214
893
2.43
31.70
1.2
1.2
u/l
74.9
69.8
0.18
163
586
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1189
8375
1.47
31.70
3.3
3.0
ng/l
253.0
224.0
1.37
1097
7659
(3035350) Ketones [Presence] in Urine by Test strip
4677
40600
1.28
31.46
4.2
3.8
estimate
0.0
0.0
1.08
1054
7479
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
63
121
5.23
31.14
2.0
1.2
ng/l
1201.5
175.2
0.43
47
85
(3019060) Gas panel - Arterial blood
944
6363
1.53
31.13
6.5
4.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
211
889
2.40
30.62
3.6
3.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
34
35
9.74
29.40
1.5
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
392
2126
1.88
29.37
2.7
2.3
g/l
119.1
128.7
8.88
280
1540
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
114
356
3.23
29.27
1.6
1.4
%
66.5
65.9
0.06
90
294
(3021601) Nitrite [Presence] in Urine by Test strip
4652
40643
1.26
28.62
5.7
5.1
estimate
0.0
0.0
0.80
1071
7575
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5052
44577
1.26
28.52
3.1
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
4695
41159
1.26
27.71
4.3
3.9
estimate
0.0
0.0
0.05
1039
7347
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
772
5109
1.55
27.57
11.8
9.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
61
127
4.83
27.52
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1530
11550
1.38
27.44
1.3
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
296
1497
2.01
27.28
2.2
1.9
mmol/l
1.7
1.7
0.08
287
1464
(40761995) Spermatozoa Progressive [#/volume] in Semen
58
117
4.98
27.15
1.6
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
58
117
4.98
27.15
3.3
6.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
666
4279
1.59
27.04
5.1
4.1
%
49.5
47.9
0.94
660
4226
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
60
126
4.78
26.80
1.3
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
74
185
4.02
26.51
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
274
1362
2.04
26.50
1.2
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
138
510
2.73
26.32
1.3
1.1
mg/l
56.4
41.6
1.96
112
423
(3001893) Eosinophils/100 leukocytes in Pleural fluid
99
303
3.29
26.31
1.6
1.4
%
2.2
2.4
0.06
80
257
(3005322) IgE [Units/volume] in Serum or Plasma
674
4383
1.58
25.98
1.5
1.3
u/ml
515.4
251.5
0.87
568
4040
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
133
486
2.76
25.93
1.2
1.1
mg/l
386.6
285.6
1.73
116
423
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
63
142
4.46
25.83
2.6
2.7
ng/l
110.4
158.9
0.70
49
71
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
24
0
+∞
25.00
1.0
0.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
658
4297
1.57
24.89
6.2
2.8
%
0.7
0.7
0.45
635
4110
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
852
5885
1.49
24.81
10.3
8.8
%
0.7
0.7
1.01
836
5848
(3000919) Neutrophils/100 leukocytes in Pleural fluid
89
268
3.34
24.31
1.6
1.4
%
18.0
20.0
0.26
80
244
(3008152) Bicarbonate [Moles/volume] in Arterial blood
860
5978
1.48
24.24
9.1
7.1
mmol/l
24.7
24.5
0.75
801
5565
(3014007) Fractional oxyhemoglobin in Arterial blood
854
5933
1.48
24.14
10.3
8.8
%
93.5
93.9
0.91
845
5908
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
850
5905
1.48
24.03
10.2
8.7
%
1.3
1.4
0.40
835
5866
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
665
4394
1.55
23.86
6.4
2.8
%
1.2
1.2
0.14
657
4366
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
736
4980
1.51
23.66
10.1
8.9
mmol/l
24.2
24.3
0.37
685
4611
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
29
7
41.50
23.57
1.1
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
82
242
3.41
23.13
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
187
846
2.23
23.11
1.4
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5641
51060
1.23
22.92
4.0
3.2
u/l
60.2
52.6
6.14
5278
46777
(3002523) Influenza virus A Ag [Presence] in Specimen
186
846
2.22
22.70
1.5
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
328
1826
1.82
22.66
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
334
1871
1.81
22.61
1.2
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1424
10988
1.34
21.79
1.5
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
70
194
3.63
21.74
1.7
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
976
7087
1.42
21.71
4.6
4.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
710
4856
1.50
21.64
3.1
2.9
e6/l
0.3
0.3
0.51
701
4757
(3046861) Legionella sp Ag [Presence] in Urine
32
45
7.13
21.59
1.1
1.0
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
57
138
4.15
21.38
1.3
1.2
mmol/l
3.3
1.3
1.27
36
90
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7721
81446
0.79
21.35
4.9
5.2
mmol/l
2.6
2.6
4.07
7002
74046
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3183
27280
1.24
21.19
2.4
2.2
u/l
172.5
230.7
3.16
3004
25428
(3051651) Icteric interference index of Serum or Plasma
136
557
2.46
21.14
6.3
3.9
—
—
—
0
0
(3013512) EKG study
3060
26128
1.24
21.05
4.8
4.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
233
1192
1.98
20.87
2.3
2.6
u/ml
203.6
604.8
0.69
228
1158
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
593
3937
1.54
20.80
7.5
5.1
%
1.6
1.6
0.20
556
3682
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
126
503
2.52
20.68
1.2
1.2
u/l
142.0
92.2
0.89
118
426
(3032057) Clostridioides difficile [Presence] in Stool
70
201
3.50
20.64
2.3
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
384
2302
1.69
20.52
1.3
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
86
283
3.06
20.36
1.1
1.1
miu/ml
1038.7
1684.8
5.50
86
283
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
70
203
3.46
20.34
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
162
729
2.24
20.34
1.1
1.1
—
74.8
—
0
13
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
44
90
4.91
20.33
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
71
208
3.43
20.31
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
730
5088
1.47
20.22
2.3
2.4
au/ml
25.1
25.3
0.01
14
210
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
506
3264
1.58
20.17
2.6
3.9
u/ml
133.5
69.5
0.54
492
3127
(3014765) Yersinia sp identified in Stool by Organism specific culture
385
2323
1.68
20.09
1.3
1.2
—
—
—
0
0
(4027681)
103
378
2.74
20.02
1.4
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
28
37
7.59
19.93
2.1
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
122
490
2.51
19.79
1.2
1.2
u/l
45.5
23.2
2.65
110
408
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
19
0
+∞
19.79
1.1
0.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
385
2333
1.68
19.77
1.3
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
105
392
2.70
19.75
1.7
4.7
mg/l
2096.2
65.6
0.49
91
278
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
76
237
3.22
19.70
1.7
1.2
%
33.7
30.9
0.11
24
27
(3023183) Ammonium ion [Moles/volume] in Plasma
323
1868
1.75
19.66
2.8
2.7
umol/l
35.2
34.4
0.21
276
1560
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
91
319
2.87
19.29
1.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
97
352
2.77
19.28
3.0
1.4
ug/l
14.3
7.9
2.57
92
316
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7472
78878
0.81
19.14
4.4
4.6
mmol/l
1.3
1.4
57.79
6767
71572
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
116
463
2.52
19.09
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
97
354
2.76
19.08
1.3
1.1
u/l
1.2
1.1
1.11
52
163
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
664
4607
1.47
18.82
1.3
1.3
au/ml
68.5
53.7
0.42
17
201
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
22
23
9.58
18.76
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
216
1118
1.95
18.75
1.4
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
351
2107
1.69
18.69
1.2
1.2
titre
108.9
134.1
0.50
36
175
(3007930) Methemoglobin/Hemoglobin.total in Blood
576
3890
1.51
18.65
8.0
5.1
%
0.9
0.9
0.62
540
3642
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
82
279
2.95
18.36
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
37
72
5.15
18.11
1.1
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
75
245
3.08
18.03
1.3
1.4
%
16.6
23.3
1.34
59
208
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
640
4448
1.47
17.97
3.2
3.2
pmol/l
4.3
4.4
2.35
572
3905
(3011325) HIV 1+2 Ab [Presence] in Serum
22
25
8.82
17.64
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
449
2911
1.57
17.53
9.1
6.1
mmol/l
1.3
1.3
0.53
393
2563
(3027035) Albumin [Mass/time] in 24 hour Urine
40
86
4.67
17.46
1.8
1.3
—
555.0
—
0
11
(3013945) Hepatitis B virus e Ab [Presence] in Serum
27
40
6.76
17.39
2.1
1.5
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
19
18
10.57
17.32
1.1
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
68
215
3.18
17.28
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
68
216
3.16
17.15
1.2
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
27
41
6.60
17.00
1.1
1.1
u/l
5.4
1.7
—
10
9
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7571
79548
0.82
16.74
4.5
4.6
mmol/l
4.4
4.5
13.76
6925
72680
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
64
199
3.23
16.73
1.2
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
90
340
2.66
16.62
1.7
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
115
495
2.34
16.12
3.4
3.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
924
6978
1.36
16.06
3.7
2.7
ml/min/173m2
59.1
63.0
2.21
420
2802
(3043410) Blood group antigens tested for on Red Blood Cells
68
226
3.02
15.92
4.1
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7209
76000
0.83
15.90
5.9
6.3
mmol/mol
40.1
40.5
2.92
6580
69458
(3011397) Hemoglobin [Presence] in Urine by Test strip
2323
19747
1.23
15.78
4.1
3.8
—
—
—
0
0
(3020891) Body temperature
545
3768
1.47
15.73
5.6
4.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
138
649
2.14
15.64
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
173
887
1.97
15.52
1.3
1.2
u/ml
42.2
54.4
0.25
15
48
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
131
3.68
15.35
4.9
6.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
312
1916
1.65
15.29
2.3
3.4
u/ml
429.9
762.5
0.45
274
1747
(3035947) Staphylolysin Ab [Units/volume] in Serum
98
404
2.44
15.15
1.2
1.1
iu/ml
3.8
3.7
—
5
22
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
258
1510
1.73
15.15
3.6
3.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
196
1058
1.87
15.08
1.2
1.2
u/ml
3.6
4.5
0.23
59
348
(44786800) Granulocytes/100 leukocytes in Body fluid
45
119
3.79
15.06
1.5
1.3
%
21.8
22.9
0.07
33
87
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
82
313
2.63
14.88
1.2
1.1
ng/l
1602.2
445.6
0.96
34
76
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
354
2282
1.57
14.23
1.8
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
364
2362
1.56
14.21
1.8
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
55
173
3.19
14.17
1.1
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
26
46
5.66
14.11
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
490
3396
1.46
13.98
1.4
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
479
3306
1.47
13.96
2.4
2.3
ug/l
409.9
626.3
1.11
444
3128
(3035637) Corticotropin [Mass/volume] in Plasma
192
1057
1.83
13.92
1.4
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
53
165
3.22
13.89
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7995
76353
1.21
13.86
32.9
14.8
ml/min/173m2
76.6
77.0
0.63
7192
63105
(3003181) Sodium [Moles/volume] in Urine
269
1636
1.66
13.73
1.4
1.4
mmol/l
60.1
62.8
0.50
227
1310
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
37
92
4.03
13.50
1.1
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
416
2811
1.50
13.48
1.3
1.2
u/ml
3.2
0.8
0.95
32
273
(3051611) Lipemic interference index of Serum or Plasma
180
985
1.84
13.32
5.4
3.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
26
49
5.32
13.22
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
102
460
2.23
12.91
1.6
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
47
143
3.30
12.81
1.1
1.1
pmol/l
1.1
5.5
—
5
21
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
40
110
3.65
12.70
1.3
1.4
%
79.3
75.4
0.33
32
92
(3022217) INR in Platelet poor plasma by Coagulation assay
1566
13039
1.24
12.64
25.2
28.2
inr
1.3
1.4
2.35
249
1793
(3024869) Neuronal Ab [Presence] in Serum
51
165
3.10
12.58
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
186
1047
1.79
12.58
1.2
1.2
u/ml
3.8
4.1
0.11
72
458
(3029937) Albumin [Presence] in Urine by Test strip
2553
22307
1.19
12.54
4.8
4.3
estimate
0.0
0.0
0.14
986
7192
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
155
825
1.89
12.54
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
100
455
2.21
12.41
1.6
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
200
1156
1.74
12.36
3.1
3.6
u/ml
41.5
33.8
0.25
193
1120
(40768446) Kidney Pathology biopsy report
77
313
2.47
12.35
1.4
1.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
34
85
4.01
12.34
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
6467
60876
1.17
12.31
4.2
3.9
pmol/l
15.0
15.0
0.01
5931
54434
(3041918) Cholesterol [Moles/volume] in Pleural fluid
55
189
2.92
12.23
1.3
1.2
mmol/l
1.5
1.6
0.53
37
112
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
114
550
2.08
12.20
1.6
1.5
u/l
6.5
6.2
0.07
66
252
(3044889) 12 lead EKG panel
6266
58870
1.16
12.14
5.0
4.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
127
640
2.00
12.08
1.1
1.2
titre
89.0
174.2
—
10
121
(3023420) DNA double strand Ab [Units/volume] in Serum
143
751
1.92
12.06
1.5
1.4
iu/ml
22.2
22.7
—
6
33
(3039000) Anion gap in Blood
322
2115
1.54
11.97
11.3
6.9
mmol/l
11.1
11.3
0.76
290
1893
(3018572) Chloride [Moles/volume] in Blood
322
2116
1.54
11.94
11.3
6.9
mmol/l
105.1
105.0
0.13
290
1894
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
230
1396
1.66
11.89
1.3
1.2
u/ml
30.7
40.6
0.69
32
145
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
72
289
2.50
11.88
1.3
1.3
ug/l
37.3
427.5
1.93
31
154
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
251
1562
1.62
11.77
1.3
1.2
u/ml
1.4
5.2
1.53
21
117
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
38
107
3.56
11.68
9.6
2.5
umol/l
39.2
41.3
0.21
32
91
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
59
4.59
11.62
1.1
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
17
24
7.09
11.41
1.1
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
42
129
3.26
11.31
1.3
1.3
u/l
29.5
302.7
0.58
30
90
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
96
449
2.15
11.17
6.6
6.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
468
3359
1.41
11.10
4.6
4.1
mmol/l
1.5
1.4
0.98
453
3302
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
94
441
2.14
10.87
1.1
1.1
u/l
42.0
29.8
0.78
69
331
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
36
103
3.50
10.83
1.1
1.2
u/l
23.8
17.7
0.71
30
69
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
94
3.63
10.76
1.1
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
46
154
3.00
10.76
1.7
1.4
%
3.9
10.4
2.92
21
79
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
94
443
2.13
10.75
1.1
1.1
u/l
110.6
91.7
1.09
74
343
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
16
23
6.97
10.56
1.1
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
8796
85273
1.21
10.55
39.4
18.4
mmol/l
139.3
139.6
22.72
8669
83045
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
299
2001
1.51
10.24
1.4
1.2
u/ml
54.1
43.6
0.29
31
108
(1761868) Lipid panel - Serum or Plasma
2218
25165
0.85
10.20
3.0
3.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
28
70
4.01
10.20
1.1
1.3
ml/s/173m2
1.7
0.9
2.65
23
41
(3041096) Erythrocytes [Presence] in Urine by Automated
2405
21223
1.17
10.15
4.1
3.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
59
234
2.53
10.05
1.3
1.2
—
—
—
0
0
(4268621)
130
710
1.84
9.81
2.1
2.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
279
1860
1.51
9.75
1.4
1.2
u/ml
2.3
4.7
0.83
38
192
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
22
47
4.69
9.75
1.5
1.2
%
19.0
36.6
1.07
16
28
(3024928) Oxygen saturation in Venous blood
288
1936
1.50
9.68
10.1
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
165
972
1.71
9.63
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
119
637
1.88
9.58
5.7
4.9
u/ml
59.0
77.0
0.26
34
187
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
280
1880
1.50
9.48
1.4
1.3
u/ml
2.4
6.7
3.53
47
301
(21494755) Public health laboratory ask at order entry panel
349
4901
0.70
9.47
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1909
21805
0.85
9.40
1.8
1.6
mmol/l
1.5
1.3
6.18
1658
18023
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
9
0
+∞
9.37
5.3
0.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
8797
85460
1.20
9.36
41.2
18.5
mmol/l
4.0
4.0
0.28
8656
83091
(3049242) von Willebrand panel - Platelet poor plasma
14
20
7.01
9.28
1.6
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
161
955
1.70
9.19
1.2
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
52
204
2.56
9.09
1.2
1.1
%
82.3
86.2
0.38
33
100
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
640
8155
0.77
9.09
1.6
1.6
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
34
106
3.21
9.00
2.5
1.6
nmol/l
0.1
0.1
0.12
28
72
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
21
6.67
8.89
2.4
8.9
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
22
51
4.32
8.85
1.1
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
36
118
3.06
8.79
1.3
1.2
%
59.2
53.0
0.30
19
50
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
75
354
2.13
8.63
2.6
2.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
361
2593
1.41
8.61
1.5
1.4
ug/g
262.7
270.8
0.34
228
1555
(3040151) Glucose [Moles/volume] in Capillary blood
176
1089
1.63
8.57
8.5
12.9
mmol/l
7.3
7.3
0.00
145
895
(3004451) EKG impression Narrative
93
478
1.95
8.50
1.3
1.3
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
21
49
4.29
8.38
1.2
1.1
u/field
1.2
1.0
0.43
12
30
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
7350
76260
0.87
8.35
4.3
4.1
mmol/l
1.4
1.3
9.29
6669
68560
(3043409) Potassium [Moles/volume] in Arterial blood
389
2848
1.38
8.29
5.0
4.4
mmol/l
3.9
3.9
1.22
353
2685
(40759836) Histone Ab [Presence] in Serum by Immunoblot
98
519
1.90
8.22
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
98
519
1.90
8.22
1.1
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
50
203
2.47
8.18
1.2
1.2
%
76.4
84.7
0.88
31
103
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
98
520
1.89
8.17
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
1114
9350
1.21
8.15
1.3
1.3
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
17
34
5.01
8.13
1.1
1.1
nmol/l
257.8
268.5
0.11
17
34
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
98
523
1.88
8.04
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
98
523
1.88
8.04
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
98
524
1.88
7.99
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1067
8935
1.22
7.99
2.1
2.3
ug/g
172.1
145.2
1.15
861
6975
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
414
3083
1.36
7.95
1.1
1.1
u/ml
23.2
7.3
—
9
44
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
238
1608
1.49
7.89
1.3
1.2
u/ml
1.7
13.2
—
6
18
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
381
5116
0.73
7.89
1.8
1.8
—
—
—
0
0
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
14
24
5.84
7.84
1.3
1.2
u/field
1.0
1.1
—
8
14
(40761535) Cells panel - Urine sediment
917
7587
1.23
7.73
4.1
3.6
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
12
8
15.01
7.70
1.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
90
474
1.91
7.70
1.9
2.0
u/field
1.8
2.8
0.83
64
321
(3017446) Testosterone [Moles/volume] in Serum or Plasma
818
6695
1.24
7.63
2.4
2.1
nmol/l
12.2
12.4
0.22
738
5808
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
37
134
2.77
7.61
1.8
3.2
mg/l
69.8
40.7
—
7
28
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3381
31098
1.13
7.47
4.6
4.1
—
—
—
0
0
(3017501) Neutrophils [#/volume] in Blood by Manual count
7
0
+∞
7.29
1.7
0.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
23
64
3.60
7.28
1.2
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
153
956
1.61
7.24
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
116
675
1.73
7.20
1.4
1.4
u/l
31.6
28.0
0.51
100
558
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
5
20.02
7.12
1.1
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
10
5
20.02
7.12
1.1
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
19
47
4.05
7.06
1.1
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
23
66
3.49
6.97
1.1
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
295
2127
1.40
6.96
4.6
3.3
mmol/l
1.5
1.7
3.42
290
2072
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
370
2772
1.35
6.88
1.7
1.6
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
33
119
2.78
6.88
1.1
1.3
nmol/l
9.8
266008.4
0.72
27
100
(3008295) Osmolality of Serum or Plasma
147
922
1.60
6.87
1.3
1.4
mosm/kgh2o
277.9
278.9
0.19
116
695
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
54
247
2.19
6.81
1.6
2.2
%
213.9
184.2
0.84
54
231
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
22
63
3.50
6.70
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
506
3977
1.29
6.68
2.6
2.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1007
8533
1.20
6.65
2.4
2.4
ug/l
7.2
7.2
0.03
851
7335
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
148
2283
0.64
6.63
1.4
1.7
mg/l
5.3
3.7
0.84
108
1634
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
104
606
1.72
6.47
2.0
2.3
nmol/l
20.9
18.2
1.50
98
569
(40768441) Liver Pathology biopsy report
103
600
1.72
6.42
1.4
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
202
1385
1.47
6.31
1.6
1.5
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
12
22
5.46
6.28
1.1
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
151
975
1.56
6.27
1.1
1.1
%
123.1
116.1
1.24
143
862
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
6
0
+∞
6.25
4.0
0.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
30
109
2.76
6.19
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
238
3308
0.71
6.19
1.4
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
77
417
1.85
6.14
1.5
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
90
512
1.76
6.11
2.4
2.5
umol/l
38.5
34.4
0.06
11
52
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
29
106
2.74
5.93
1.3
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
63
324
1.95
5.88
2.7
2.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
20
59
3.39
5.85
1.2
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
29
107
2.72
5.83
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2113
19151
1.13
5.68
1.7
1.7
pmol/l
38540941.0
27335047.9
0.25
1754
15570
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
32
126
2.54
5.68
11.2
11.7
mmol/l
5.8
5.5
0.16
32
126
(3032743) Legionella sp IgG Ab [Presence] in Serum
17
46
3.70
5.63
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
101
611
1.66
5.54
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
33
134
2.47
5.51
2.3
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
17
47
3.62
5.47
1.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
118
746
1.59
5.43
1.1
1.1
%
86.7
95.9
3.34
113
692
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
8
5
16.02
5.40
1.1
1.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
246
1805
1.37
5.32
1.8
1.7
mu/l
311.8
298.1
0.33
235
1650
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
18
53
3.40
5.29
1.1
1.2
—
—
—
0
0
(3006969) Lambda light chains [Mass/volume] in Urine
11
22
5.00
5.25
1.0
1.0
g/l
0.2
0.0
—
5
9
(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
5
0
+∞
5.21
12.4
0.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
31
126
2.46
5.18
1.2
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
8826
86485
1.14
5.18
26.4
10.6
u/l
26.6
26.1
1.30
8689
82917
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
69
384
1.80
5.11
1.2
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
23
82
2.81
4.96
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
41
193
2.13
4.92
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
46
228
2.02
4.83
2.0
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
7454
72422
1.10
4.83
37.5
16.8
%
37.0
39.4
69.28
4876
48190
(3033705) Calcium.ionized [Moles/volume] in Venous blood
174
1227
1.43
4.79
3.4
2.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
26
101
2.58
4.79
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
270
2054
1.32
4.66
3.1
3.1
nmol/l
0.8
0.8
0.13
184
1583
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
112
728
1.54
4.64
2.7
3.5
u/ml
45.8
49.8
0.08
112
718
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
12
29
4.14
4.62
1.5
1.3
—
—
—
0
0
(4015189)
51
269
1.90
4.51
2.1
2.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
87
2.65
4.47
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
106
687
1.55
4.46
18.7
2.5
%
9.8
11.1
2.31
106
687
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
97
617
1.58
4.43
1.2
1.2
—
—
—
0
0
(4306422)
145
1006
1.45
4.40
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
78
471
1.66
4.39
2.1
2.0
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
27
112
2.41
4.37
3.8
6.1
ug/min
71.4
46.0
0.94
27
90
(3029075) Extractable nuclear Ab panel - Serum
41
203
2.02
4.35
1.1
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2667
28577
0.91
4.19
4.1
4.0
mg/mmol
13.9
10.2
2.43
1790
18182
(40758358) Immune stain study
11
27
4.08
4.15
1.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
79
487
1.63
4.13
1.3
1.3
u/ml
1.4
1.3
0.03
42
237
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
146
1028
1.43
4.12
1.1
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
27
116
2.33
4.07
1.0
1.5
—
13.7
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
24
535
0.45
3.98
1.9
1.5
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
9
14
6.43
3.98
1.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
23
93
2.48
3.95
1.3
1.1
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
8
11
7.28
3.85
1.4
1.3
mg/l
2.1
1.3
—
8
11
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
49
271
1.81
3.80
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
452
3755
1.21
3.79
2.1
1.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
23
95
2.42
3.79
1.3
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
7
8
8.75
3.77
1.0
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
7
8
8.75
3.77
2.6
2.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
95
627
1.52
3.75
1.3
1.2
mmol/l
34.4
35.0
0.10
88
528
(3034426) Prothrombin time (PT)
47
258
1.83
3.74
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
112
766
1.47
3.72
2.0
2.2
u/field
1.3
1.9
0.95
49
286
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
39
202
1.93
3.70
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
84
542
1.55
3.68
4.4
2.5
ph
7.4
7.4
0.15
32
205
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
591
5047
1.18
3.67
1.4
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
31
148
2.10
3.67
1.1
1.2
%
80.6
79.4
0.05
11
51
(3018291) Platelet Ab [Presence] in Serum
9
16
5.63
3.65
1.0
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
148
1070
1.39
3.64
1.1
1.1
g/l
1.6
1.5
1.41
139
956
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
31
149
2.08
3.61
1.1
1.2
%
68.3
75.2
0.36
12
50
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7768
79321
0.92
3.55
5.1
4.9
mmol/l
6.0
6.0
1.15
7058
71238
(3051387) C reactive protein [Mass/volume] in Capillary blood
244
1908
1.29
3.54
4.0
3.6
mg/l
31.2
29.0
0.44
175
1224
(3025130) Human papilloma virus identified in Specimen
94
630
1.50
3.48
2.2
1.7
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
17
63
2.70
3.48
1.8
3.9
mg/l
22.0
18.8
0.41
17
58
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
384
4630
0.82
3.47
1.7
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1769
16296
1.10
3.43
1.3
1.3
u/ml
1.6
1.9
0.55
361
4074
(3014271) Vancomycin [Susceptibility]
82
536
1.53
3.42
3.1
2.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
16
58
2.76
3.41
1.1
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
16
59
2.71
3.31
1.9
4.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
41
225
1.83
3.31
1.1
1.6
g/l
16.5
13.4
1.52
31
181
(3002814) Trichinella spiralis Ab [Titer] in Serum
6
7
8.58
3.26
1.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
73
473
1.55
3.19
1.5
1.6
u/l
7.1
6.3
0.30
57
399
(1002224) Polysomnography panel
206
2632
0.78
3.18
1.1
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
21
91
2.31
3.16
3.3
5.9
g/mol
141.3
616.6
0.39
21
78
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
36
193
1.87
3.14
2.0
2.6
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
16
61
2.63
3.12
1.1
1.1
u/ml
0.0
0.9
—
9
36
(3020961) Endomysium IgA Ab [Titer] in Serum
401
3367
1.20
3.08
1.1
1.1
titre
94.0
177.1
—
5
83
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
36
195
1.85
3.05
1.6
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
536
4624
1.17
3.00
4.1
3.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
14
51
2.75
2.98
1.2
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
15
57
2.63
2.96
3.8
3.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
435
5104
0.85
2.96
1.8
2.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
16
63
2.54
2.95
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
84
572
1.47
2.94
2.5
2.1
umol/l
11.3
9.8
0.14
60
417
(40768793) Breast Pathology biopsy report
194
1515
1.29
2.91
1.4
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
68
444
1.54
2.90
1.3
1.2
u/l
200.4
435.7
1.48
63
408
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
6
9
6.67
2.86
2.2
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2661
28127
0.93
2.85
4.1
4.6
%
21.9
22.1
0.25
1306
14553
(1761482) Bacteria [#/volume] in Urine by Culture
304
2507
1.22
2.84
4.7
4.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
24
116
2.07
2.82
2.0
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
61
393
1.56
2.78
1.2
1.1
ratio
1.1
1.1
0.52
24
127
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
9
23
3.92
2.77
1.0
1.0
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
5
6
8.34
2.75
15.4
6.5
ug/l
6.1
6.7
—
5
6
(3029396) Erythrocyte agglutination [Presence] in Blood
18
78
2.31
2.74
1.4
2.5
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
66
435
1.52
2.72
1.9
2.3
mmol/l
9.2
9.2
0.04
48
335
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
559
4879
1.15
2.71
2.5
2.5
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
6
10
6.00
2.69
1.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
6
10
6.00
2.69
1.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
44
264
1.67
2.68
2.6
1.8
mmol/l
0.4
0.6
0.10
39
245
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
58
375
1.55
2.62
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
106
1433
0.74
2.54
1.5
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
14
56
2.50
2.52
2.1
2.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
41
247
1.66
2.48
4.5
4.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
35
202
1.74
2.47
1.7
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
19
89
2.14
2.44
1.1
1.1
iu/ml
12.0
15.8
—
8
36
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
65
0.00
2.41
0.0
1.8
—
1.6
—
0
54
(4038314)
9
27
3.34
2.39
1.1
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
69
474
1.46
2.38
2.3
2.2
—
—
—
0
0
(3016750) Collection duration of Urine
77
541
1.43
2.36
2.1
2.2
min
501.8
494.8
0.26
48
400
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
84
602
1.40
2.31
1.3
1.3
titre
32.5
69.0
—
8
52
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
97
716
1.36
2.25
1.4
1.6
u/ml
34.3
24.3
0.74
13
157
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1893
20097
0.93
2.24
2.9
3.2
ug/l
0.8
0.8
0.50
1308
14097
(3001019) Free T4 and TSH panel - Serum or Plasma
212
2576
0.82
2.20
1.6
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
62
891
0.69
2.20
1.4
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
21
107
1.96
2.19
1.7
1.6
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
17
80
2.13
2.18
1.1
1.4
mmol/l
190.1
165.9
0.18
11
70
(3009508) Creatinine [Moles/volume] in Urine
2697
28251
0.94
2.15
3.2
3.2
mmol/l
7.2
7.5
2.90
2258
23385
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
44
672
0.65
2.14
1.5
1.5
—
—
—
0
0
(4146454)
77
1055
0.73
2.08
2.8
2.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
73
1006
0.72
2.05
1.1
1.1
u/ml
8.1
4.8
0.53
33
531
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
40
616
0.65
2.04
2.1
1.7
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
10
38
2.63
2.00
1.4
1.4
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
10
38
2.63
2.00
1.3
1.2
u/field
1.0
1.2
—
5
20
(3006270) Folate [Moles/volume] in Blood
101
766
1.32
1.99
1.2
1.2
nmol/l
354.8
334.9
0.37
78
619
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
64
451
1.42
1.98
2.4
2.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
71
976
0.73
1.98
1.1
1.1
u/ml
0.7
1.1
0.40
29
446
(3034614) HLA Ag [Interpretation]
5
11
4.55
1.94
2.0
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
32
195
1.64
1.92
1.6
1.5
ug/l
0.4
0.4
0.55
25
113
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
17
85
2.00
1.89
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
113
880
1.29
1.86
1.1
1.1
u/ml
1.8
3.3
1.80
35
335
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
226
1900
1.19
1.85
1.1
1.1
u/ml
4.7
8.9
1.09
21
178
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
77
572
1.35
1.78
1.1
1.1
mg/l
314.9
286.1
2.09
69
509
(3000492) Spirometry study
790
7243
1.10
1.77
1.7
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
139
1119
1.25
1.76
1.3
1.4
mu/l
55.2
69.1
0.50
125
986
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
22
124
1.78
1.75
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
491
4394
1.12
1.74
1.2
1.2
iu/ml
114.1
132.2
0.48
145
1548
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
7534
74205
1.06
1.73
5.0
4.7
mu/l
2.4
2.2
0.24
6940
66806
(3027540) Rickettsia typhi Ab [Titer] in Serum
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
87
1131
0.77
1.70
1.2
1.1
u/ml
3.2
1.8
0.33
33
493
(3051101) Glucose [Moles/volume] in Cord blood
8
180
0.44
1.67
4.4
6.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
38
251
1.52
1.67
2.2
2.7
ug/l
1.1
1.2
0.22
38
235
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
7
25
2.80
1.65
3.0
3.3
—
—
—
0
0
(3025315) Body weight
14
69
2.03
1.64
5.1
4.9
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
16
83
1.93
1.64
1.7
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
11
49
2.25
1.63
2.1
3.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
80
608
1.32
1.62
2.1
2.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
64
471
1.36
1.60
1.0
1.1
nmol/l
0.1
10.6
—
9
101
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
48
336
1.43
1.60
2.3
2.0
umol/l
77.2
132.3
1.70
25
181
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
16
84
1.91
1.59
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
58
421
1.38
1.58
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
129
1047
1.23
1.56
1.2
1.3
pmol/l
313.4
309.4
0.03
108
793
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1350
12722
1.07
1.55
1.2
1.3
iu/ml
41.5
36.5
0.46
403
3865
(3010726) Horse dander IgE Ab [Units/volume] in Serum
68
899
0.75
1.53
1.1
1.1
u/ml
3.6
2.6
0.21
19
226
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
170
2023
0.84
1.52
1.5
1.9
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
21
123
1.71
1.50
1.6
1.7
pmol/l
57.6
51.7
0.10
21
98
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
37
250
1.48
1.49
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
646
5928
1.10
1.46
1.2
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
44
615
0.71
1.44
1.1
1.1
u/ml
0.4
0.3
0.43
13
168
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
13
67
1.94
1.38
1.2
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
134
1113
1.21
1.34
1.2
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
18
297
0.61
1.33
2.9
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
146
1733
0.84
1.31
1.4
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
218
2505
0.87
1.30
1.7
2.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
141
1181
1.20
1.30
1.9
2.2
mg/l
31.1
25.7
0.41
34
295
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
69
534
1.29
1.28
2.4
1.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
72
916
0.78
1.27
1.2
1.2
mmol/l
7.3
7.7
0.39
51
662
(40768800) Prostate Pathology biopsy report
200
2304
0.87
1.25
1.2
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
39
278
1.40
1.23
6.3
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
39
278
1.40
1.23
6.3
2.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
32
220
1.46
1.23
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
26
171
1.52
1.22
1.2
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
185
1596
1.16
1.22
2.0
1.9
pmol/l
200.3
199.1
0.05
177
1489
(3003338) MCHC [Mass/volume]
6606
67017
0.96
1.21
48.6
20.2
g/l
330.7
332.2
31.94
6558
66399
(3019150) Specific gravity of Urine by Refractometry
1888
18118
1.05
1.20
4.7
4.3
kg/l
1.0
1.0
0.20
279
2789
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
125
1045
1.20
1.20
1.4
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
16
94
1.70
1.17
1.6
1.8
—
—
—
0
0
(4010399)
573
6191
0.92
1.15
1.4
1.4
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
20
2.50
1.15
2.0
5.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
39
2.05
1.15
1.1
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
52
396
1.31
1.12
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
32
226
1.42
1.09
1.1
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
8
41
1.95
1.08
1.9
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
2629
27100
0.96
1.07
4.3
3.3
mg/l
2918.0
307.1
26.02
1819
17372
(3028300) Cannabinoids [Presence] in Urine
162
1863
0.87
1.04
1.4
2.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
13
216
0.60
1.04
1.8
3.7
mg/l
12.1
7.8
—
7
179
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
245
2185
1.12
1.03
1.8
1.8
nmol/l
43.5
42.8
0.16
238
2094
(3021788) Differential panel - Synovial fluid
186
1631
1.14
1.02
1.6
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
162
1857
0.87
1.00
1.4
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
159
1821
0.87
0.98
1.4
2.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
49
379
1.29
0.97
1.1
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
38
284
1.34
0.96
1.4
1.9
e6/l
9470.1
16871.8
0.38
25
155
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
9
51
1.77
0.94
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
162
1847
0.88
0.94
1.4
2.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
101
852
1.19
0.93
1.5
1.3
e6/l
93843.8
137037.9
0.25
71
580
(1001926) Buprenorphine [Presence] in Urine by Screen method
125
1450
0.86
0.93
1.5
2.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
42
321
1.31
0.92
1.6
2.1
e6/l
2613.3
3601.0
0.14
32
218
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
332
3628
0.91
0.91
1.0
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
133
1151
1.16
0.91
1.3
1.3
nmol/l
0.2
0.3
0.98
11
83
(4281824)
96
810
1.19
0.89
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
113
969
1.17
0.88
1.4
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
135
1548
0.87
0.87
1.7
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
16
103
1.55
0.87
2.5
2.7
u/field
0.4
0.5
0.05
16
103
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
8
44
1.82
0.85
7.3
9.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
13
80
1.63
0.84
1.0
1.2
umol/24h
2.3
1.7
1.55
13
80
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
16
104
1.54
0.84
1.8
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
47
591
0.79
0.83
1.3
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
239
2164
1.11
0.82
1.8
1.6
e6/l
16277.5
14764.4
0.19
180
1572
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1171
11228
1.05
0.82
11.9
7.7
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
18
260
0.69
0.80
1.4
1.5
mmol/l
7.5
8.2
0.47
12
155
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
24
172
1.40
0.80
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
161
1430
1.13
0.79
2.0
1.5
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
37
287
1.29
0.76
1.1
1.1
%
94.1
95.8
0.16
30
215
(3004775) Volume in Urine collected for unspecified duration
91
779
1.17
0.75
2.3
2.3
ml
741.9
653.9
0.93
55
515
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
54
440
1.23
0.75
1.1
1.1
iu/ml
13.2
10.8
—
10
102
(3021162) Amylase [Enzymatic activity/volume] in Specimen
23
166
1.39
0.75
2.7
2.8
u/l
504.0
2278.5
1.41
16
154
(3010813) Leukocytes [#/volume] in Blood
8929
89776
0.96
0.75
55.1
22.8
e9/l
8.6
6.8
30.49
8735
86810
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
13
83
1.57
0.74
1.2
1.3
pmol/l
18.4
21.0
0.11
13
72
(3020123) Porphyrins [Interpretation] in Serum or Plasma
7
38
1.84
0.73
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
28
210
1.33
0.73
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
28
210
1.33
0.73
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
28
210
1.33
0.73
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
28
210
1.33
0.73
1.0
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
8930
89779
0.96
0.73
55.4
22.9
g/l
124.9
135.0
307.65
8836
88251
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
15
100
1.50
0.72
1.9
2.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
71
598
1.19
0.72
1.2
1.3
mmol/l
11.2
11.6
0.17
27
177
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
10
60
1.67
0.72
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
8929
89762
0.96
0.71
55.1
22.8
e12/l
4.1
4.5
307.65
8734
86798
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
98
849
1.16
0.71
1.2
1.3
—
45.2
—
0
5
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1237
11923
1.04
0.71
1.2
1.2
u/ml
8.7
13.9
2.12
385
4340
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
75
636
1.18
0.71
1.7
1.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
27
203
1.33
0.70
1.1
1.4
g/l
25.8
26.7
0.11
21
158
(3024731) MCV [Entitic volume]
8929
89755
0.96
0.70
54.9
22.7
fl
92.5
91.3
94.06
8836
88215
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
22
160
1.38
0.70
10.3
7.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
8929
89753
0.96
0.70
54.8
22.7
pg
30.6
30.4
26.77
8837
88212
(3041672) Baker's yeast Ab [Presence] in Serum
7
41
1.71
0.70
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
115
1010
1.14
0.69
1.3
1.3
nmol/l
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
14
93
1.51
0.69
7.1
10.6
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
59
1.53
0.68
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
265
2444
1.09
0.66
1.5
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
30
384
0.78
0.65
1.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
8928
89720
0.96
0.65
55.2
22.8
e9/l
217.4
244.9
194.84
8752
87072
(43055442) Apixaban [Mass/volume] in Serum or Plasma
21
154
1.36
0.64
1.3
1.6
ug/l
147.6
111.0
0.84
16
130
(3002619) Bacteria identified in Specimen by Culture
24
180
1.33
0.64
1.4
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
54
643
0.84
0.62
1.1
1.0
ng/l
38.7
42.8
0.41
36
422
(3010015) Selenium [Moles/volume] in Serum or Plasma
10
63
1.59
0.61
1.8
2.2
umol/l
1.3
1.3
—
10
58
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
34
271
1.26
0.60
1.0
1.3
umol/l
2.6
3.8
1.78
28
247
(3033799) Differential panel - Peritoneal fluid
37
298
1.24
0.60
1.5
2.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
27
209
1.29
0.60
13.6
8.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
215
1978
1.09
0.59
2.5
2.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
8
52
1.54
0.59
1.1
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
167
1.32
0.56
2.0
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
31
247
1.26
0.56
12.2
8.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
88
0.57
0.56
1.0
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
63
731
0.86
0.55
1.1
1.1
u/ml
5.2
4.1
0.13
26
303
(4024509)
97
860
1.13
0.55
1.5
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
194
1785
1.09
0.55
1.7
1.7
iu/l
6.9
4.5
0.90
59
576
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
73
637
1.15
0.53
1.3
1.2
u/ml
93.8
64.9
—
8
28
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
9
63
1.43
0.52
1.1
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
55
640
0.86
0.51
1.1
1.0
ng/l
343.2
321.9
0.15
37
429
(3028707) Methadone [Presence] in Urine by Screen method
75
853
0.88
0.51
1.5
2.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
137
1246
1.10
0.51
1.6
1.6
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
55
639
0.86
0.50
1.1
1.0
ng/l
825.2
722.7
0.77
35
415
(3013139) Helicobacter pylori Ag [Presence] in Stool
503
5267
0.95
0.49
1.2
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
14
190
0.74
0.49
1.1
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
87
775
1.12
0.48
1.4
1.3
nmol/l
1.3
1.5
1.20
73
692
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
40
336
1.19
0.47
1.3
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
106
1172
0.90
0.46
4.9
4.7
umol/l
345.9
354.7
0.25
91
1001
(4034850)
253
2696
0.94
0.46
14.8
10.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
69
782
0.88
0.46
1.5
1.5
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
7
50
1.40
0.45
1.1
1.1
—
27.7
—
0
13
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
31
257
1.21
0.43
1.6
2.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
63
713
0.88
0.42
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
593
5710
1.04
0.42
3.2
3.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
63
712
0.88
0.42
1.4
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
194
1.24
0.41
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
63
711
0.89
0.41
1.4
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
56
491
1.14
0.41
11.0
10.9
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
35
296
1.18
0.40
2.5
2.8
umol/l
26.0
28.0
0.56
28
222
(3044009) aPTT.lupus sensitive (LA screen)
8
60
1.33
0.40
1.3
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
63
709
0.89
0.40
1.4
1.4
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
7
103
0.68
0.39
1.4
1.3
—
89.8
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
5
35
1.43
0.39
1.4
3.1
mmol/l
4.4
4.4
—
5
35
(3036670) Protein [Mass/volume] in Synovial fluid
36
308
1.17
0.37
1.3
1.2
g/l
36.2
40.2
1.04
19
155
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
32
271
1.18
0.37
1.5
1.4
pmol/l
16.4
16.3
0.02
26
220
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
15
191
0.79
0.36
1.6
2.0
mg/l
8.1
9.5
—
9
158
(3023430) Cat dander IgE Ab [Units/volume] in Serum
60
671
0.89
0.35
1.1
1.1
u/ml
2.4
4.8
1.14
27
285
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
20
162
1.23
0.35
1.5
1.9
ug/l
2.0
2.1
—
9
83
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1066
10912
0.97
0.35
4.1
4.8
%
31.0
32.8
5.95
761
7209
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
10
73
1.37
0.34
1.3
1.1
u/l
4.3
14.2
—
10
73
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
25
297
0.84
0.33
1.3
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
118
1.27
0.33
1.3
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
92
1.30
0.31
1.2
2.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
42
370
1.14
0.31
2.4
2.1
umol/l
58.3
56.3
0.14
37
298
(3034891) Synovial lining cells/100 cells in Synovial fluid
39
443
0.88
0.31
1.4
1.5
%
6.1
3.6
0.22
14
101
(3017509) Phencyclidine [Presence] in Urine
7
53
1.32
0.30
1.0
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
10
131
0.76
0.30
1.3
1.6
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
10
75
1.33
0.30
1.4
1.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
21
250
0.84
0.30
9.9
5.8
%
69.9
71.5
0.13
15
200
(4211845)
42
470
0.89
0.27
2.9
3.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
816
8344
0.98
0.27
1.6
1.7
%
1.5
1.5
0.66
691
7150
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
121
1136
1.07
0.27
1.6
1.6
%
58.9
60.8
0.22
81
720
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
26
224
1.16
0.27
1.1
1.3
%
49.1
34.6
1.09
19
146
(4133840)
17
204
0.83
0.26
1.3
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
55
501
1.10
0.25
2.3
2.1
ug/min
122.3
155.4
0.11
14
122
(3024263) Appearance of Synovial fluid
51
463
1.10
0.25
1.7
1.6
—
—
—
0
0
(4094501)
217
2265
0.96
0.25
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
31
273
1.14
0.25
1.2
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
28
245
1.14
0.24
2.1
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
55
601
0.91
0.24
1.5
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
89
831
1.07
0.24
1.5
1.5
%
33.5
28.4
0.65
60
521
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
87
1.26
0.24
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
16
133
1.20
0.24
1.3
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
47
516
0.91
0.23
1.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
53
578
0.92
0.23
1.5
1.3
pmol/l
53.3
115.1
0.60
25
177
(3051339) Copper [Moles/volume] in Blood
5
40
1.25
0.22
1.0
1.2
umol/l
18.7
17.0
—
5
32
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
39
352
1.11
0.22
1.7
1.7
nmol/l
2.0
5.8
2.04
34
296
(3012494) Peanut IgE Ab [Units/volume] in Serum
16
189
0.85
0.22
1.0
1.1
u/ml
0.6
6.3
—
6
106
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
135.6
—
0
10
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
1.5
—
0
10
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
6.8
—
0.2
—
0
12
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806420)
27
304
0.89
0.21
2.9
2.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
89
837
1.06
0.21
3.6
3.1
mg/l
122.7
46.4
0.54
64
613
(3001556) Androgen free Index in Serum or Plasma
5
43
1.16
0.21
1.2
1.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3492
35165
0.99
0.20
4.6
5.3
ug/l
3.8
3.7
0.05
3097
31328
(3027570) Oxalate [Moles/time] in 24 hour Urine
6
49
1.22
0.20
1.0
1.4
umol/24h
440.2
327.3
—
6
49
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
115
0.78
0.20
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
143
1369
1.05
0.19
1.6
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
10
81
1.23
0.18
1.7
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
127
1329
0.96
0.18
1.4
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
30
271
1.11
0.18
1.2
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
24
214
1.12
0.17
1.5
1.6
ug/l
10.3
9.3
0.31
24
214
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
123
1178
1.04
0.17
1.1
1.1
iu/ml
10.6
830.9
0.95
17
260
(3027923) C peptide [Moles/volume] in Serum or Plasma
50
466
1.07
0.16
1.8
1.3
nmol/l
1.1
1.2
0.51
35
358
(3026726) Creatinine [Moles/volume] in Specimen
9
79
1.14
0.15
3.2
2.5
umol/l
801.7
519.8
—
9
73
(3011288) Drugs identified in Urine by Screen method
119
1237
0.96
0.14
2.0
3.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
36
333
1.08
0.14
1.0
1.2
u/ml
1.8
2.6
0.21
16
131
(3047352) Trisomy 18 risk [Likelihood] in Fetus
55
583
0.94
0.14
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
55
582
0.94
0.13
1.4
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
117
0.85
0.13
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
40
427
0.94
0.12
3.0
3.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
63
662
0.95
0.12
1.9
1.9
ug/l
2.9
3.7
0.87
56
583
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
21
231
0.91
0.12
1.0
1.3
nmol/l
89.8
141.8
2.93
15
171
(3005082) Progesterone [Moles/volume] in Serum or Plasma
16
143
1.12
0.11
1.4
1.4
nmol/l
29.2
30.3
0.07
16
119
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
161
1652
0.97
0.11
2.0
1.7
nmol/l
1.0
0.8
3.02
134
1373
(3011048) Pyruvate [Moles/volume] in Blood
5
46
1.09
0.09
1.0
1.2
umol/l
61.2
89.4
—
5
40
(3033923) Metanephrine [Moles/time] in 24 hour Urine
19
175
1.09
0.08
1.0
1.2
umol/24h
0.8
0.7
0.55
13
80
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
88
1.14
0.08
1.7
1.6
umol/l
42.6
42.1
—
10
88
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
29
307
0.94
0.07
1.2
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
71
0.84
0.07
1.3
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
31
327
0.95
0.07
1.1
1.1
u/ml
15.0
1.6
0.42
12
114
(3028717) Thiamine [Mass/volume] in Blood
7
85
0.82
0.07
1.0
1.2
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
11
99
1.11
0.06
1.0
1.3
—
110.3
—
0
7
(40761511) CBC panel - Blood by Automated count
8418
84107
1.00
0.06
29.7
14.9
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
22
207
1.06
0.06
2.9
2.2
mmol/l
6.5
7.9
2.27
11
132
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
222
2247
0.99
0.05
1.5
1.8
—
—
—
0
0
(4198724)
24
251
0.96
0.04
1.3
2.7
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
27
281
0.96
0.04
1.1
1.1
u/ml
0.2
2.2
—
7
51
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
234
2319
1.01
0.04
2.4
2.4
ug/min
158.3
108.1
0.59
143
1350
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
38
370
1.03
0.03
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
22
229
0.96
0.02
1.5
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
55
542
1.01
0.01
1.6
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
65
642
1.01
0.01
1.2
1.4
promille
1.1
1.3
0.47
40
496
(3020491) Glucose [Moles/volume] in Blood
61
617
0.99
0.01
1.3
2.0
mmol/l
7.6
6.9
0.95
46
423
(3025577) Chromium [Mass/volume] in Blood
64
647
0.99
0.01
2.0
2.0
ug/l
2.0
2.3
0.54
53
534
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
880
8789
1.00
0.01
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
201
2018
1.00
0.01
1.1
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
11
116
0.95
0.00
1.3
2.2
mmol/l
1.2
1.6
—
5
79
(44813793)
46
466
0.99
0.00
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
64
646
0.99
0.00
1.3
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
104
0.96
0.00
4.2
2.0
umol/l
22.8
18.4
—
10
104
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
162
0.99
0.00
1.5
1.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
19
187
1.02
0.00
1.3
1.3
mg/l
1.4
86.1
1.25
13
142
(37021550) Renin [Units/volume] in Plasma --upright
20
197
1.02
0.00
1.4
1.3
mu/l
74.5
81.7
0.07
15
143
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
180
1805
1.00
0.00
1.4
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
118
1.02
0.00
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
16
155
1.03
0.00
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
24
242
0.99
0.00
1.3
2.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
111
0.99
0.00
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
76
0.92
0.00
1.1
1.2
—
—
—
0
0
(44806071)
8
86
0.93
0.00
1.1
1.1
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
68
0.88
0.00
1.3
1.2
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.8
—
14.0
—
0
5
(3036180) Methadone [Presence] in Urine
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
159.1
—
0
7
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
6
64
0.94
0.00
1.5
1.5
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC – Primary_lymphoid and hematopoietic malignant neoplasms

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).